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ABSTRACT 
 
A shuttle vector was constructed which was stably maintained in Escherichia coli, 
Bacillus subtilis and Staphylococcus aureus. It was made by ligating E. coli positive 
selection plasmid pEcoR251 and S. aureus resistance plasmid pC194 via their respective 
BamHI and XhoII sites. Designated pNDW1, it was shown to be effective in genomic 
library construction. The number of restriction sites in the EcoRI (“suicide”) gene was 
increased by successive addition of XbaI and XhoI using site-directed mutagenesis. SpeI, 
NheI and AvrII generate DNA fragments with compatible cohesive ends to XbaI while 
SalI digestion gives rise to ends compatible with XhoI.  Therefore the number of different 
genomic libraries which can be made using this system is augmented by six. A principal 
impediment to full exploitation of these shuttle vectors is apparently the severe restriction 
by B. subtilis and S. aureus of DNA coming from E. coli.  
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1. INTRODUCTION 
 
1.1 The genus Bacillus  
 
Bacillus subtilis is a rod-shaped, spore-forming, non-pathogenic Gram-positive bacterium 
found in soil and vegetation. They can contaminate food, however, seldom result in food 
poisoning. They are used on vegetable and soybean seeds as fungicide. Some strains 
cause rots on potatoes and ropiness in bread. Bacillus thuringiensis is a bacterium in the 
same genus known to be used in insect control. Bacillus cereus and Bacillus licheniformis 
can cause food poisoning. Bacillus anthracis causes anthrax, an acute and sometimes 
lethal disease of humans and animals. It has been identified as a potential bioterrorism 
attack agent (Hughes and Gerberding, 2002).  
 
Bacillus species produce a wide range of hydrolytic enzymes that breakdown complex 
polymers such as polysaccharides, nucleic acids and lipids, permitting the organism to 
use these products as carbon sources and electron donors. Many Bacillus species produce 
antibiotics, of which bacitracin, polymyxin, tyrocidine, gramicidin and circulin are 
examples. Strains of Bacillus polymyxa biosynthesize a number of useful and potentially 
useful compound, including peptide antibiotics, proteases, and a wide variety of 
carbohydrates-utilizing enzymes, such as β-amylase, β-D-xylanases, pullulanase, glucose 
isomerase and polygalacturonate lyase (Malloonee and Speckman, 1989). Frequently 
these enzymes are secreted making them easier to purify. B. subtilis has proven highly 
amenable to genetic manipulation, and has therefore become widely adopted as a model 
organism for laboratory studies, especially of sporulation, which is a simplified example 
of cellular differentiation In terms of popularity as a laboratory model organism B. 
subtilis is often used as the Gram-positive equivalent of Escherichia coli, an extensively 
studied Gram-negative rod. 
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1.2 Staphylococcus Spp. 
 
Taxonomically, the genus Staphylococcus is in the bacterial family Staphylococcaceae, 
which includes three lesser known genera, Gamella, Macrococcus and Salinicoccus. The 
Listeriaceae are also a closely related family. Staphylococcus aureus forms a fairly large 
yellow colony on rich medium. S. epidermidis has a relatively small white colony. S. 
aureus is often hemolytic on blood agar; S. epidermidis is non hemolytic. Staphylococci 
are facultative anaerobes that grow by aerobic respiration or by fermentation that yields 
principally lactic acid. The bacteria are catalase-positive and oxidase-negative. S. aureus 
can grow at a temperature range of 15 to 45 degrees and at sodium chloride 
concentrations as high as 15 percent. Nearly all strains of S. aureus produce the enzyme 
coagulase: nearly all strains of S. epidermidis lack this enzyme. S. aureus should always 
be considered a potential pathogen; most strains of S. epidermidis are nonpathogenic and 
may even play a protective role in their host as normal flora. Staphylococcus epidermidis 
may be a pathogen in the hospital environment (Madigan et al., 2003). Staphylococci are 
perfectly spherical cells about 1 micrometer in diameter. They grow in clusters because 
staphylococci divide in two planes. The configuration of the cocci helps to distinguish 
staphylococci from streptococci, which are slightly oblong cells that usually grow in 
chains (because they divide in one plane only). The catalase test is important in 
distinguishing streptococci (catalase-negative) from staphylococci, which are vigorous 
catalase-producers. The test is performed by adding 3% hydrogen peroxide to a colony on 
an agar plate or slant. Catalase-positive cultures produce O2 and bubble at once. The test 
should not be done on blood agar because blood itself contains catalase (Todar, 2005). 
 
Staphylococcus aureus causes a variety of suppurative (pus-forming) infections and 
toxicoses in humans. It causes superficial skin lesions such as boils, styes and 
furunculosis; more serious infections such as pneumonia, mastitis, phlebitis, meningitis, 
and urinary tract infections; and deep-seated infections, such as osteomyelitis and 
endocarditis (Madigan et al., 2003). S. aureus is a major cause of hospital acquired 
(nosocomial) infection of surgical wounds and infections associated with indwelling 
medical devices. S. aureus causes food poisoning by releasing enterotoxins into food, and 
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toxic shock syndrome by release of super antigens into the blood stream. S. aureus 
expresses many potential virulence factors: (1) surface proteins that promote colonization 
of host tissues; (2) invasins that promote bacterial spread in tissues (leukocidin, kinases, 
hyaluronidase); (3) surface factors that inhibit phagocytic engulfment (capsule, Protein 
A); (4) biochemical properties that enhance their survival in phagocytes (carotenoids, 
catalase production); (5) immunological disguises (Protein A, coagulase, clotting factor); 
and (6) membrane-damaging toxins that lyse eukaryotic cell membranes (hemolysins, 
leukotoxin, leukocidin; (7) exotoxins that damage host tissues or otherwise provoke 
symptoms of disease; (8) inherent and acquired resistance to antimicrobial agents. 
 
For the majority of diseases caused by S. aureus, pathogenesis is multifactorial, so it is 
difficult to determine precisely the role of any given factor. However, there are 
correlations between strains isolated from particular diseases and expression of particular 
virulence determinants, which suggests their role in a particular disease. The application 
of molecular biology has led to advances in unraveling the pathogenesis of 
staphylococcal diseases. Genes encoding potential virulence factors have been cloned and 
sequenced, and many protein toxins have been purified. With some staphylococcal 
toxins, symptoms of a human disease can be reproduced in animals with the purified 
protein toxins, lending an understanding of their mechanism of action (Todar, 2005).  
 
Hospital strains of S. aureus are usually resistant to a variety of different antibiotics. A 
few strains are resistant to all clinically useful antibiotics except vancomycin, and 
vancomycin-resistant strains are increasingly-reported. The term MRSA refers to 
Methicillin resistant Staphylococcus aureus. Methicillin resistance is widespread and 
most methicillin-resistant strains are also multiple resistant. In addition, S. aureus 
exhibits resistance to antiseptics and disinfectants, such as quaternary ammonium 
compounds, which may aid its survival in the hospital environment. S. aureus responded 
to the introduction of antibiotics by the usual bacterial means to develop drug resistance: 
(1) mutation in chromosomal genes followed by selection of resistant strains and (2) 
acquisition of resistance genes as extra-chromosomal plasmids, transducing particles, 
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transposons, or other types of DNA inserts. S. aureus expresses its resistance to drugs and 
antibiotics through a variety of mechanisms.   
 
1.3 Plasmids 
 
Plasmids represent an important factor in bacterial evolution. They enable rapid short-
term adaptation of the bacterial host to changing environmental conditions and allow 
amplification of gene by transferring them within one or between many species. 
Normally, plasmids are nonessential to their hosts, conferring only an energy burden that 
can slow cell growth. They can, however, be stably maintained in a bacterial population 
even under non selective conditions. Copy number of a plasmid is maintained by 
regulation of replication. Low copy number plasmid requires a tighter regulation of 
regulation and segregation than the high copy number (Kües and Stahl, 1989).  
 
 
1.4 Staphylococcus aureus plasmids 
 
Many small plasmids conferring resistance to different antibiotics have been isolated 
from Staphylococcus aureus (te Riele et al., 1986). Since the discovery of staphylococcal 
plasmids in the early 1960s, three general classes have been identified and characterized. 
The first S. aureus plasmids discovered were of class II. These are of intermediate size 
and copy number; they encode a combination of β-lactamase and inorganic ion 
resistances, and they occur in S. aureus plus various other species such as Staphylococcus 
xylosus and Staphylococcus simulans. Plasmids of class I were discovered shortly 
afterward. These are of small size (1-5 kb) and high copy number (15-50 copies per cell); 
they usually encode a single antibiotic resistance, and they occur in many staphylococcal 
species. Most recently, a number of larger (30-60 kb) plasmids carrying multiple 
antibiotic resistances have been identified (Novick, 1989). 
 
Class II plasmids are larger (15-30Kb), have a lower copy numbers and carry some 
combination of resistance to β-lactam antibiotics (β-lactamase), macrolides and a variety 
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of heavy metal ions  such as arsenic, cadmium, lead and mercury (Novick and Roth, 
1968). Some of these plasmids are reported to be transposable. Class III consists of a 
considerably larger (30-60Kb) plasmids that carry a determinant of conjugative transfer, 
tra, plus some combination of resistance markers including gentamycin and penicillin 
Qa, some are transposable and contain a number of insertion sequence like elements 
(Gray, 1983). Staphylococcal plasmids are of particular importance in the study of 
antibiotic resistance of S. aureus because using plasmids isolated from this organism 
might help understand the how these resistant determinants are being transferred to other 
species and to other genera.  
 
1.5 Plasmid pC194 
 
Plasmid pC194 is one of the several small (2.9kb in size) found in S. aureus reported by 
Iordanescu et al. (1978). Plasmid pC194 specifies chloramphenicol-induced resistance to 
chloramphenicol mediated by the enzyme chloramphenicol acetyl-transferase (CAT), an 
enzyme that inactivates chloramphenicol by converting it successively to the inactive 3-
acetyl and 1, 3-diacetyl derivatives. It has served as a useful vector for analytical cloning 
of determinants of inducible resistance and replication in conjugation studies of another 
small plasmid, pE194 (Horinouchi and Weisblum, 1982). It can also serve as a useful 
system for studies of gene expression control mechanism since the synthesis of CAT 
appears to be under autogenous control. Plasmid pC194 is of interest because it can 
replicate in a wide variety of bacterial hosts (Goze and Ehrlich, 1980). It was also found 
to be maintained in the yeast Saccharomyces cerevisiae (Goursot et al., 1982). This 
maintenance of these plasmids in different bacterial species might be attributed to 
horizontal gene transfer as a normal phenomenon. 
 
1.6 Restriction modification system 
 
The restriction modification system (RM system) is used by bacteria, and perhaps other 
prokaryotic organisms to protect themselves from foreign DNA, such as bacteriophages. 
This phenomenon was first noticed in the 1950s. Certain bacteria strains were found to 
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inhibit (restrict) the growth of viruses grown in other strains. This effect was attributed to 
sequence-specific restriction enzymes. Bacteria have restriction enzymes, also called 
restriction endonucleases, which cleave double stranded DNA at specific points into 
fragments, which are then degraded further by other endonucleases. This prevents 
infection by effectively destroying the foreign DNA introduced by an infectious agent 
such as a bacteriophage (Figure 1.1 B). Approximately one quarter of known bacteria 
possess RM systems and of those about one half has more than one type of system 
(Wilson, 1991a; Wilson, 1991b). 
 
Restriction enzymes only cleave at specific sequences of DNA which are usually 4-6 
base pairs long, and often palindromic. Given that the sequences that the restriction 
enzymes recognize are very short, the bacterium itself will almost certainly have many of 
these sequences present in its own DNA. Therefore, in order to prevent destruction of its 
own DNA by the restriction enzymes, the bacterium marks its own DNA by adding 
methyl groups to it. This modification must not interfere with the DNA base-pairing, and 
therefore, usually only a few specific bases are modified on each strand (Wilson, 1991b). 
 
A restriction endonuclease recognizes a specific DNA sequence and introduce double-
stranded break and the modification enzyme recognizes the same sequence and protects  
it from the restriction enzyme by methylation Figure 1.1 A. It has been hypothesized that 
several restriction-modification gene complexes in bacteria are not easily replaced by 
competitor genetic elements because their loss leads to cell death (Naito et al., 1995; 
Handa et al., 2001; Figure. 1C). This finding led to the proposal that these complexes 
may actually represent one of the simplest forms of life, similar to viruses, transposons, 
and homing endonucleases. This selfish gene hypothesis (Naito et al., 1995; Kusano et 
al., 1995; Kobayashi, 2001) is now supported by many lines of evidence from genome 
analysis and experimentation. After loss of the restriction-modification gene complex, the 
restriction enzyme and modification enzyme will become increasingly diluted through 
cell division. Finally, too few modification enzyme molecules remain to defend all the 
recognition sites present on the newly replicated chromosomes. Any one of the remaining 
molecules of the restriction enzyme can attack these exposed sites. The chromosome 
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breakage then leads to extensive chromosome degradation, and the cell dies unless the 
breakage is somehow repaired. The chromosome breakage may stimulate recombination 
and generate a variety of rearranged genomes, some of which might survive. The 
principle of post-segregational killing once established in a cell, the addiction gene 
complex is difficult to eliminate because its loss, or some sort of threat to its persistence, 
leads to cell death. Intact copies of the gene complex survive in the other cells of the 
clone.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Represents the action of a restriction-modification gene complex (Adapted 
from Kobayashi, 2004). A Restriction enzyme (Endonuclease) cleaves unmethylated 
DNA and modification methyltransferase protects the DNA from cleavage. B Attack on 
incoming DNA. An attack on invading DNA that is not appropriately methylated is likely 
to be beneficial to the restriction-modification gene complex and to its host. C A simple 
dilution model for post-segregational killing. 
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1.7 Types of Restriction Modification Systems 
 
There are three kinds of restriction modification systems: type I, type II and type III, all 
with restriction enzyme activity and a methylase activity. They were named in the order 
of discovery, although the type II system is the most common. Type I systems are the 
most complex, consisting of three polypeptides: R (restriction), M (modification), and S 
(specificity). The resulting complex can both cleave and methylate DNA. Both reactions 
require ATP, and cleavage often occurs a considerable distance from the recognition site. 
The S subunit determines the specificity of both restriction and methylation. Cleavage 
occurs at variable distances from the recognition sequence, so discrete bands are not 
easily visualized by gel electrophoresis (Wilson and Murray, 1991). Type II systems are 
the simplest and the most prevalent. Instead of working as a complex, the 
methyltransferase and endonuclease are encoded as two separate proteins and act 
independently (there is no specificity protein). Both proteins recognize the same 
recognition site, and therefore compete for activity. The methyltransferase acts as a 
monomer, methylating the duplex one strand at a time. The endonuclease acts as a 
homodimer, which facilitates the cleavage of both strands. Cleavage occurs at a defined 
position close to or within the recognition sequence, thus producing discrete fragments 
during gel electrophoresis. For this reason, Type II systems are used in labs for DNA 
analysis and gene cloning. Type III systems have R and M proteins that form a complex 
of modification and cleavage. The M protein, however, can methylate on its own. 
Methylation also only occurs on one strand of the DNA unlike most other known 
mechanisms. The heterodimer formed by the R and M proteins competes with itself by 
modifying and restricting the same reaction. This results in incomplete digestion (Wilson 
and Murray, 1991). 
 
A hypothesis was proposed that the certain type II RM systems may represent selfish 
genetic elements in the sense that they can maintain and increase their copy number even 
when they do not confer any advantageous phenotype on their host cells (Kobayashi, 
2001; Naito et al., 1995). This hypothesis was based on the observation that certain type 
II RM systems on a plasmid can increase stability of a plasmid by selectively killing cells 
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that failed to retain the plasmid, thereby causing an increase in their relative frequency in 
the viable bacterial population. Analysis of bacterial genomes provided evidence that RM 
systems can move between bacterial genomes, which seems to be consistent with the 
behavior as selfish DNA elements (Kobayashi, 2001; Naderer et al., 2002; Nobusato et 
al., 2000). The selfish hypothesis was given strong support when the RM system on a 
chromosome was found to multiply in tandem in a manner dependent on a functional 
restriction gene (Sadykov et al., 2003). This was reminiscent of the induction of the 
replication of prophage genomes. Type II RM systems show similarities to viruses in 
their regulation of gene expression (Kobayashi, 2004). When they enter a new host, they 
have to establish themselves in the host without excessive killing the host cells, just like a 
temperate bacteriophage establish themselves in the host cells as prophages. It is 
postulated that the RM gene system express the modification activity before restriction 
activity to protect the host chromosome by methylation. The methyl-transferases of type 
II RM systems were shown to function as transcriptional regulators required for 
coordinated expression of the restriction and the modification enzyme (Som and 
Friedman, 1993). 
 
 In some type II RM systems, a third regulatory protein, called C protein, plays the role of 
delaying expression of their restriction enzymes (Nakayama and Kobayashi, 1998; Tao et 
al., 1991). After establishment, the type II RM system are expected to tight regulate their 
gene expression to maintain constant cellular levels of restriction enzyme and 
modification enzyme to prevent attack on the host, just as a prophages do until critical 
events such as gene loss happens to trigger the attack. Type II RM systems are of 
particular importance because the plasmid used in this study has an EcoRI endonuclease 
gene of the EcoRI RM system. The EcoRI system is composed of the ecoRIR (R) and 
ecoRIM (M) genes, which encode EcoRI R and M proteins, respectively (Liu et al., 
2007). The R gene is located upstream of the M gene. It has been proposed that the R and 
M genes constitutes an operon, in which expression of the two genes is coordinately 
controlled by a promoter located immediately upstream of the R gene (Liu et al., 2007). 
In addition, a specific promoter for the M gene has been proposed to be present within 
the R. gene. This postulated M gene-specific promoter, which should allow expression of 
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the M gene in the absence of the R gene, might play a role for sequential expression of 
the modification activity and restriction activity when the EcoRI gene system enters a 
new host cell (Liu et al., 2007). 
 
1.8 Positive selection vectors 
 
Non-recombinant transformants in DNA cloning experiments are a problem that is 
especially troublesome when the relative amount of target DNA is low or when the 
percentage of recombinants must be maximized, as when constructing a genomic library. 
Several approaches have been taken to resolve this problem such as treatment of the 
vector with phosphatase prior ligation and cutting the vector with restriction enzymes that 
produce ends that are non-complementary so that the inserts will have the complementary 
ends that could easily ligate to the vector. These methods have disadvantages of being 
subjected to the variable efficiencies of the enzymatic reactions and purifications used to 
prepare the vector for cloning. A number of positive selection vectors have been 
generated which employ genetic means to eliminate transformants carrying religated or 
uncut vector. Such vectors typically rely upon the inactivation of a lethal gene, 
inactivation of a dominant function conferring cell sensitivity to metabolites, removal of 
a lethal site or the depression of an antibiotic-resistance function. Positive selection 
vectors have the advantages of being simpler to use, more efficient, and more reliable 
than biochemical methods for the selection of recombinants (Kuhn, 1986). 
 
 These plasmids have proven useful for the selection and expression of a number of genes 
from a variety of organism. A number of positive-selection vectors have been constructed 
for example Cheng and Modrich (1983) have constructed a plasmid that has a functional 
endonuclease gene and a non functional modification gene. This plasmid is under the 
control of the PL promoter of the bacteriophage lambda (λ). When this plasmid is 
introduced in a host that has a functional methyltransferase activity the endonuclease 
activity is inhibited. If it is introduced into a lambda lysogen the endonuclease gene is 
controlled and insertion of DNA into the unique restriction sites on the endonuclease 
gene abolishes the endonuclease activity (Cheng and Modrich, 1983).   
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Kuhn et al. (1986) have also constructed a series of positive selection plasmid vectors. 
The principle of selection in these plasmids is based on the separation of the EcoRI 
restriction and modification functions. The vectors carry either a wild-type or mutant 
endonuclease gene, the expression of either of which is lethal in the absence of active 
EcoRI methylase. DNA cloned into any of the several unique restriction sites within the 
endonuclease gene disrupts its lethal function, allowing induced transformed cells 
carrying recombinant plasmids to survive, while cells carrying non-recombinant plasmids 
are killed. These vectors have an advantage over the other positive selection vectors 
because their expression is induced chemically rather than thermally (such in the case of 
plasmids employing induction by lambda promoters by inactivation of a temperature 
sensitive lambda repressor). Expression of this vectors constructed by Kuhn et al (1986) 
is under the control of the lac operon.   
 
1.18.1 Plasmid pEcoR251 
 
Plasmid pEcoR251 is about 3.3kb in size. The EcoRI endonuclease gene is placed under 
the control of the PR promoter of phage lambda (λ) and this plasmid can therefore be 
maintained in a λ lysogen of E. coli since the phage λ infects E. coli. This plasmid has an 
ampicillin resistance gene which can be used to select for transformants containing this 
plasmid. When a piece of DNA is inserted into the one of the unique restriction sites in 
the endonuclease gene, the endonuclease gene is disrupted leading to the endonuclease 
activity being destroyed. This property can be used to select for transformants in a non-
lysogen that have incorporated an insert in the endonuclease gene and those that did not 
incorporate an insert will die due to the expression of a functional EcoRI endonuclease 
(Dabbs et al., 1990).  
 
In a λ lysogen the expression of the suicide gene is under the control of the PR promoter 
and the regulation of the expression of the endonuclease gene is by a λ repressor protein 
called CI857. In a lysogen the CI repressor silences the lytic genes (Svenningsen et al., 
2005).  Plasmid pEcoR251 is constructed by fusing the 180bp fragment of the phage λ 
chromosome bearing the PR promoter and the first 96bp of the cro gene. The 
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endonuclease gene is fused in frame with the cro gene and the expression of this gene is 
under the control of the PR promoter (Zabeau and Stanley, 1982). In a λ lysogen the 
prophage expresses a repressor protein that binds to the cro operator region and thus 
inhibiting the expression of the EcoRI endonuclease gene. Figure 1.2 shows the 
regulation of the expression of the suicide gene by the repressor protein. In a non lysogen 
there is no repressor protein being expressed to block transcription of the EcoRI suicide 
gene, hence the death of cell containing this plasmid.  
 
 
 
 Repressor protein binds to Operator region 
 
 
  
 
 
 
Figure 1.2: Regulation of the expression of the suicide gene. O is the operator region of 
the cro gene 
 
 
1.9 Regulatory element from lambda phage 
 
PL and PR promoters of the λ phage are widely used as promoters for the expression 
vectors. This type of vectors can be regulated in combination with a λ cI857 repressor 
gene which codes for a temperature-sensitive repressor. At 28-30˚C, this repressor is 
active and represses the transcription from the λ promoters. At 42˚C, the temperature-
sensitive repressor protein is inactive and transcription from the λ promoters is 
derepressed. A λ prophage can be used as a carrier for the cI857 repressor gene only if 
the regulatory unit lacks lytic functions resident on prophages. Otherwise cells would be 
killed after heat induction (Mieschendahl and Müller-Hill, 1985). With this properties of 
O      Cro        EcoR gene PR promoter 
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the λ lysogen together with the properties of the EcoRI endonuclease gene provide a 
better system for selection of recombinants transformants. When cells carrying a plasmid 
that encodes a suicide gene which is controlled by the PR promoter are grown on a non-
lysogen only recombinant transformants will be observed and when grown in a lysogen 
the expression of the endonuclease gene is repressed by the temperature-sensitive 
repressor protein 
 
1.10 Justification and Aim 
 
Antimicrobial resistance in pneumococci, enterococci and staphylococci is a norm. S. 
aureus is a pathogen of greatest concern because of its intrinsic virulence, its ability to 
cause array of life-threatening infections and its capacity to adapt to different 
environmental conditions. The mortality rate of S. aureus remains approximately 20-40% 
despite the availability of effective antimicrobials (Mylotte et al., 1987) and is now the 
leading overall cause of nosocomial infections. As more patients with S. aureus are 
treated outside the hospital setting, it is an increasing concern in the community. S. 
aureus isolates from blood samples world wide are increasingly resistant to a great 
number of antimicrobials. Inevitably this has left fewer effective bactericidal antibiotics 
to treat infection caused by the multidrug resistant S. aureus. Even when new antibiotics 
are used against S. aureus it can develop mechanisms to neutralize the antibiotic. This 
simply means that new antibiotics have to be discovered or that other ways of treating 
infection have to be used. The use of bacteriophages as therapeutic agents is probably the 
way to go. The bacteriophage expresses some proteins that inhibit the growth of the 
pathogen. So genes responsible for the inhibition of the growth of the bacteria have to be 
screened. This can be accomplished by having a vector that can be used to construct a 
genomic library in which the screening can be done. Therefore the aim of this work was 
to construct a shuttle vector for E. coli, B. subtilis and S. aureus that will facilitate the 
construction of genomic library in E. coli and screening these in S. aureus or B. subtilis. 
Also to increase the versatility of the shuttle vector by introducing unique restriction 
sites.   
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 2. MATERIALS AND METHODS 
 
2.1 Bacterial strains and plasmids used in this work 
 
Strains   Characteristics   Source 
Escherichia coli 
 MM294-4  endA1, hsdR17, gyrA   E. Dabbs 
 λ MM294-4  λ lysogen of MM294-4  E. Dabbs 
 MJ109   recA1, endA1, gyrA96, thi, hsdR17,  
                                   supE44, relA1, ∆(lac-proAB)/F' 
                                              [traD36, proAB
+
, lacI
q
, lacZ∆M15] Y. Shibayama 
 
B. subtilis 
 IA3   cysE14, purA26, trpC2  E. Dabbs 
 168                              (pC194) Cm trpC2                              Bacillus Genetic 
                                                                                                 Genetic Stock Centre 
                                                                                                  (BGSC) 
 QB944 KIT-1            cysE14 purA26 trpC2    BGSC 
 QB934 KIT-3            glyB133 metC3 tre-12 trpC2             BGSC 
 QB922 KIT-5           gltA292 trpC2                                        BGSC 
 QB917 KIT-8           hisA1 thrC5 trpC2  BGSC    
  
ND1   iri
-
 mutant of IA3 which is 
    Rifampicin resistant   This work 
 ND3   Mutant of IA3 which is 
    Streptomycin resistant  This work 
 
 
B. polymyxa  
ATCC 842   Wild type isolates    BGSC 
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_______________________________________________________________________  
S. aureus                  Microbiology  
                            Department (Wits) 
Streptomyces pseudogriseolus  M. Chengalroyen 
 
           
________________________________________________________________________ 
Plasmids  Characteristics    Source 
 
pDA71  E. coli-Rhodococcus shuttle vector  Quan and Dabbs  
(1993) 
pDA71*  E. coli-Rhodococcus shuttle vector 
   with the EcoRI suicide gene interrupted E. Dabbs 
pUC19   E. coli cloning vector with lacZ´ gene Fermentas 
pC194   S. aureus original isolate with Cm
R   
BGSC
 
pEcoR251  E. coli suicide vector with Amp
R 
 
   resistance gene    E. Dabbs 
pNDW1  E. coli-B. subtilis shuttle vector  This work 
pNDW4  pNDW1 with a 1.8Kb PstI fragment  This work 
pNDW2  E.coli-B. subtilis shuttle vector joined  
   in different restriction sites   This work 
pNDW3  E.coli-B. subtilis shuttle vector joined  
   in different restriction sites   This work 
pNDW5  pNDW1::  XbaI restriction site  This work 
pDA71 -1  pDA71:: XbaI restriction site   This work 
pNDW6  pNDW5:: fragment of genomic DNA This work 
pNDW7  pNDW5:: XhoI site    This work 
pEcoR251-1  pEcoR251::XhoI site    This work 
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2.2 Media and growth conditions 
 
Luria-Bertani (LB) (Appendix) media was used for growing E. coli and Bacillus strains 
and Brain Heart Infusion (BHI) (Appendix) media was used to grow S. aureus. Liquid 
cultures were achieved by inoculating a single bacterial colony into 5ml LB medium and 
incubated at 37°C overnight. For short-term storage, E. coli strains were kept on LB-agar 
plates at 4ºC and Bacillus strains were kept on LB-agar at room temperature. S. aureus 
was kept on BHI agar plates at room temperature. 
 
2.3 Determination of minimum inhibitory concentration (MIC) 
 
The minimum inhibitory concentration of antibiotics was determined on LB-agar plates 
for E. coli and B. subtilis by agar dilution method. Freshly grown colonies were 
inoculated into 200µl of sterile distilled water per well of the replicator plate. This was 
then transferred to the antibiotics plates with a multipoint inoculator. Antibiotic-free 
plates were used as positive controls. The spot test results were analyzed after incubation 
at 37°C for 24 hours.  
 
2.4 DNA preparation 
 
2.4.1 E. coli bulk plasmid preparation 
 
A single colony was used to inoculate 100 ml of LB with appropriate selective agent for 
the maintenance of the plasmid. The culture was grown with gentle agitation at 37°C for 
overnight. Cells were harvested by spinning in a JA-10 rotor (Beckman) at 6 000 
revolutions per minutes (rpm) for 10 minutes (min) and then resuspended in 5 ml of 
solution I (Appendix). A 10 ml of solution II (Appendix) was then added to the cell 
suspension and mixed gently by inversion. The mixture was left to stand at room 
temperature for 15 min. Then 7.5 ml of solution III (Appendix) was added and shaken 
vigorously and then left on ice for 15 min.  
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The cell debris were removed by spinning in a pre-chilled (4°C) JA-20 rotor at 15 000 
rpm for 10 min. The supernatant was transferred to a sterile JA-20 centrifuge tube and the 
DNA was precipitated with 12ml of isopropanol. The precipitation process was allowed 
to continue at room temperature for 15minutes. This was followed by centrifugation of 15 
000 rpm for 15 min at room temperature. The supernatant was decanted off and the DNA 
pellet washed with 2ml of ethanol. The ethanol was gently poured off and the DNA pellet 
was vacuum-dried for 20 min. The DNA was then re-suspended in 4ml TE buffer 
(Appendix) for 2 hours with gently agitation. Thereafter, 4.1 g of cesium chloride (CsCl) 
was added and dissolved by gently mixing and then 600µl of 1% ethidium bromide 
(EtBr) solution was added. The refractive index was adjusted to between 1.387 and 1.389 
(0.001 units =100mg CsCl if the index was below or 0.001 units= 100µl TE if the index 
was above). The mixture was loaded into a Beckman Quick-seal tube using a Pasteur 
pipette. The tube was sealed, balanced and ultra-centrifuged overnight at 45 000rpm in a 
Beckman vertical VTi 65.2 rotor. The plasmid DNA was extracted from the tube using a 
needle attached to a hypodermic syringe. DNA was purified in section 2.5.1.3 
 
2.4.2 B. subtilis bulk genomic DNA preparation 
 
A B. polymyxa culture was grown for 8 hours in 200ml LB at 37°C. Cells were harvested 
by centrifugation in a Beckman JA-10 rotor at 6 000rpm for 10 min at room temperature. 
The cells were resuspended in 5 ml of TE buffer to which 5mg/ml of lysozyme was 
added and incubated for 1 hour at 37°C. The cells were centrifuged at 8 000rpm for 5 min 
in a Beckman JA-20 rotor and resuspended in 4 ml TE buffer to which minute quantity of 
proteinase K was added. A 1/10 volume of Solution B (Appendix) was added to the cells 
and the tube incubated at 45°C for 30 min. The viscous solution was transferred to a 50Ti 
tube and spun at 40 000rpm for 30 minutes in a Beckman L5-50 ultracentrifuge. The 
supernatant was transferred to a clean JA-20 centrifuge tube and 4.4 g of CsCl was 
added. The contents of the tube were mixed by inversion of the tube for several times. 
The solution was centrifuged at 15 000 rpm in a Beckman JA-20 rotor for 15 min. The 
liquid was decanted, 600µl of 1% EtBr solution was added to it and the refractive index 
adjusted to between 1.391 and 1.392. The solution was loaded into a Beckman Quick seal 
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tube and centrifuged for overnight at 45 000 rpm in a VTi65.2 rotor in a Beckman L5-50 
ultracentrifuge. The genomic DNA was extracted from the tube using a needle attached to 
a hypodermic syringe. DNA was purified in section 2.5.1.3.  
 
2.4.3 E. coli mini plasmid preparations 
 
Individual bacterial colony was inoculated into 1ml of LB containing the appropriate 
selective agent. This was incubated at 37°C with agitation for overnight. The culture was 
transferred into sterile Eppendorf tube and the cells harvested by microfuging for 1 min. 
The supernatant was decanted off and the pellet resuspended in 80µl of solution I by 
vortexing. Then 160µl of solution II was added to the cell suspension and mixed by 
gently inversion of the tube. The tube was left to stand at room temperature for 15 min. 
Thereafter, 120µl of solution III was added and the mixture shaken vigorously and kept 
on ice for 5 min. Cellular debris was removed by microfuging in the cold room (4°C) for 
10 min. The supernatant was collected into a new sterile Eppendorf tube and placed in a 
water bath (42°C) for 2 min to warm the supernatant. Isopropanol (220µl) was added and 
the precipitation process allowed continuing at room temperature for 5 min followed by 
centrifuging at room temperature for 5 min. The pellet was washed with 150µl ethanol 
and vacuum-dried for 20 min. The DNA was then resuspended in 100-150µl of sterile 
distilled water containing freshly boiled ribonuclease (RNaseA) (1µl of 10mg/ml). A 
small aliquot was analyzed on an agarose gel.  
 
2.4.4 B. subtilis mini plasmid preparation 
 
Single colonies were inoculated in 1ml LB containing appropriate selective agent and 
grown for overnight at 37ºC. The culture was transferred into sterile Eppendorf tube and 
the cells harvested by microfuging for 1 min at room temperature. The pellet was re-
suspended in 200µl of TE buffer to which lysozyme (5mg/ml) were added. The 
suspension was incubated for 1 hour in a 37ºC water bath with inversion of the tube in 10 
min intervals. Thereafter, 40µl of TE-SDS (10%) was added and the tube mixed by 
inversion and left to stand at room temperature for 10 minutes. A volume of 40µl of 5 M 
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KAc (pH 6.0) was then added and the mixture was shaken vigorously and left on ice for 5 
min. The mixture was microfuged for 5 min in the cold room (4ºC) and the supernatant 
was transferred into a fresh Eppendorf tube. DNA was purified by phenol-chloroform 
extraction in 2.5.1.4 and precipitated by salt and ethanol precipitation in 2.5.1.1. 
 
2.5 DNA manipulations and cloning techniques 
 
2.5.1 DNA precipitation 
 
2.5.1.1 Salt and ethanol precipitation 
 
DNA was precipitated from aqueous solution with 1/3 volume of 1M NaCl and 2 
volumes of ethanol. The mixture was microfuged at 4°C for 20 min. The supernatant was 
decanted and the remaining liquid removed by blotting on a paper towel. The DNA pellet 
was vacuum-dried for 10-20 min and resuspended in the appropriate volume of sterile 
distilled water. RNaseA (10mg/ml) was used to remove contaminating RNA. 
 
2.5.1.2 Isopropanol DNA precipitation 
 
After the addition of isopropanol (220µl), the solution was mixed by inversion and left to 
stand at room temperature for 5 min. The solution was then centrifuged at room 
temperature for further 5 min. The pellet was washed with 150µl of 96% ethanol and 
vacuum-dried for 20 min. The plasmid was resuspended in an appropriate volume of 
sterile distilled water containing RNaseA.  
 
 2.5.1.3 DNA precipitation from CsCl gradient 
 
Ethidium Bromide (EtBr) was removed from the DNA by thorough mixing with 0.1 
volume of butanol. EtBr suspended in butanol forms a top layer in the tube, which is 
removed. This procedure was repeated at least 3 times until there were no traces of EtBr. 
This left the DNA in CsCl solution. The DNA was stored at -20°C until required. The salt 
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was removed by adding 2 volumes of sterile distilled water and 2.5 volumes of 96% 
ethanol and precipitated by centrifugation at 4°C for 20 min. The pellet was vacuum-
dried and resuspended in appropriate volume of sterile distilled water. 
 
2.5.1.4 Phenol-chloroform extraction 
 
The DNA solution in water was extracted by addition of 1/3 volume TE-saturated phenol 
(Appendix), mixed by inversion and microfuged at room temperature for 5 min to 
separate the organic and aqueous phases. The upper aqueous layer was transferred into a 
new sterile Eppendorf tube and where necessary, as in the case of extracting DNA from 
agarose gels, a further phenol step was performed. Then 1/3 volumes of chloroform was 
then added to the aqueous layer and mixed gently by inversion. The organic and aqueous 
layers were separated by microfuging at room temperature for 2 min. The upper aqueous 
layer was transferred into a sterile Eppendorf tube and the DNA was precipitated by the 
addition of 1/3 volume of NaCl (Appendix) as described in 2.5.1.1. 
 
2.5.2 Restriction enzyme digestion     
 
Enzymes were obtained from Fermentas, Boehringer Mannheim, New England Biolabs, 
Amersham or Promega and used according to manufacturer’s instructions. The total 
volume of digestion was 15µl (13.5µl DNA and 1.5µl 10× buffer). The mixture was 
tapped briefly to ensure even buffer distribution and spun down for a couple of seconds. 
0.3-1µl of restriction endonuclease was added and the contents mixed and re-spun 
briefly. Digestions were incubated at the appropriate temperature for maximal enzyme 
activity for at least 4 hours. For double digestions an appropriate buffer in which both 
enzymes showed suitable activity was selected, otherwise the digestions were performed 
sequentially starting with the enzyme that require a lower incubation temperature.  
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2.5.3 Ligation of DNA    
 
T4 DNA ligase (Fermentas) was used for all ligations procedures. The total volume for 
ligation was kept minimal at 20µl. Ligation buffer and the appropriate volume of  sterile 
distilled water were added to the DNA sample, mixed by tapping and microfuged for a 
couple of seconds. Subsequently, 1µl of ligase was added, remixed and re-spun. Ligation 
was performed in a water bath at 22°C for 16-22 hours. 
 
2.5.4 Alkaline phosphatase treatment  
 
Calf intestinal alkaline phosphatase (Boehringer Mannheim)  was used to prevent the 
vector from re-ligating to itself. The alkaline phosphatase removes the 5´-phosphate that 
is necessary for the ligation by DNA ligase. Following the digestion of vector DNA, 1µl 
of calf intestinal alkaline phosphatase was added to the reaction mixture. Addition of 10× 
dephosphorylation buffer was added (1/10 volume). The reaction mixture was incubated 
at 37°C for overnight. Immediately after incubation, the enzyme was removed by a 
phenol-chloroform DNA extraction as previously described in 2.5.1.1. 
 
2.6 Gel electrophoresis 
  
2.6.1 Agarose gel electrophoresis 
 
Agarose solutions stock solutions were prepared in 0.5× TBE buffer (Appendix) at 
concentrations of 0.4%, 0.8% or 1.2% depending on a fragment size to be separated. The 
solutions were sterilized by autoclaving (121°C, 20 minutes). Fragment sizes ≥10kb were 
analyzed on 0.4% agarose gels, 2-10kb on 0.8% agarose gel and ≤3kb on 1.2% agarose 
gel. Gels were prepared by melting the agarose stock solution in a microwave oven. A 
volume of 25ml of the melted agarose was mixed with 2.5µl of a 1% EtBr solution 
(Appendix). The mixture was poured in a gel tray with a 12-tooth well comb and allowed 
to polymerize at 4°C for 20 min. Combs were removed when the gel had completely set. 
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The electrophoresis buffer was 0.5× TBE mixed with 1% EtBr solution. DNA samples 
were loaded with 2µl of bromophenol blue tracking dye. GeneRuler 
TM
 DNA 1KB ladder 
Plus mix (Fermentas) was used in all electrophoretic runs using a Hoefer PS 500xdc 
power supply. The process was carried out at room temperature, 80V and a current of 21-
28mA, until the dye front reached the bottom of the gel. DNA sizes were quantified from 
standard curve generated from migrations distances of known molecular weight marker 
sizes run on the same gel. The concentrations were estimated by comparing the intensity 
of the bands to bands of similar intensity and known concentration. The DNA was 
visualized and captured using the UVP BioDoc-It
TM 
system.  
 
2.6.2 The freeze-squeeze method of extracting DNA from agarose gels 
 
DNA was digested with appropriate restriction endonuclease and fragments were 
separated on agarose gel. The fragment of interest was excised from the gel with a scalpel 
while viewing under long wavelength UV light (366nm).  The gel slice was transferred 
into a sterile Eppendorf tube where it was crushed with a sterile spatula. The crushed 
slice of gel was kept at -70ºC for 30 min and it was thawed at room temperature. 
Following thawing it was microfuged for 6 min and the supernatant collected into a 
sterile tube. A second round of crushing, freezing, thawing and centrifuging was done. 
The DNA which was suspended in the collected supernatant was purified by phenol-
chloroform extraction in 2.5.1.4. The DNA was re-suspended in appropriate volume of 
sterile distilled water.    
 
2.7 Transformations 
 
2.7.1 E. coli standard CaCl2 transformation 
 
A flask containing 20 ml of pre-warmed LB supplemented with 0.5% glucose (Appendix) 
was inoculated with 200µl of an overnight culture of E. coli MM294-4. The culture was 
incubated with vigorous shaking at 37ºC until the OD600 of 0.2-0.4 had been reached. 
That OD was generally obtained by incubating for a minimum of 1hour 45 min - 2 hours. 
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The flask was chilled in an ice-water slurry for 5 min and the cells were harvested in a 
pre-chilled Beckman JA-20 rotor at 10 000 rpm for 5 min at 4ºC. The supernatant was 
discarded and the cells re-suspended in 10 ml of ice cold transformation buffer (CaCl2 
transformation buffer) (Appendix). The cell suspension was placed on ice for 15 min and 
re-centrifuged at 10 000 rpm for 5 min. The supernatant was decanted and the cells re-
suspended in 1.3 ml of transformation buffer. The cells were left on ice for 2-24 hours in 
the cold room (4ºC). 
 
 Aliquots 100µl of the cell suspension were placed into pre-chilled sterile Eppendorf 
tubes and about 3µl of plasmid DNA was added and mixed with the cells by bubbling air 
through. The DNA plus cell suspension was left on ice for 15 min to allow for diffusion. 
The cells were then heat-shocked at 42ºC for 90 seconds. A volume of 1ml of pre-
warmed LB was added to the cells after heat shocking and incubated for 60- 90 min at 
37ºC to allow phenotypic expression of the resistance genes. The cells were then spread 
onto LB-agar containing an appropriate selective agent and further incubated for 
overnight at 37ºC. Colonies were visible after the overnight incubation for E. coli strains. 
 
2.7.2 B. subtilis electroporation 
 
A pre-culture of B. subtilis IA3 grown on LB was inoculated into 5ml of LB 
supplemented with 10.3% sucrose and grown for 4 hours at 37ºC. After incubation 1ml of 
the culture was microfuged for 1 minutes and the supernatant was decanted. The cells 
were re-suspended in ice-cold SHMG buffer (Appendix). The cells were washed twice in 
SHMG buffer and re-suspended in 500µl of the same buffer. A volume of 100µl of the 
cell suspension was transferred into a pre-chilled sterile Eppendorf tube and 5µl of the 
DNA was added, mixed by bubbling air through. The mixture was placed on ice for 15 
min to allow diffusion. The mixture was then transferred into pre-chilled Bio-Rad 
electroporation cuvette and electroporated using capacitance of 25µFD, voltage of 2.0kV 
and resistance of 200Ω and the time constant was recorded. After the electroporation 1ml 
of warm LB was added to the cells immediately and transferred into Bjorn bottles and 
incubated at 37ºC with shaking for overnight to allow phenotypic expression. After 
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incubation the cells were spread on selective media and further incubated for 2 days for 
growth to be observed.   
 
2.7.3 Protoplast transformation of B. subtilis and S. aureus  
 
This is a method described by Cohen and Cheng (1979) with modification by Zhang et al. 
(2005). Mid-log phase culture, freshly grown in LB at 37ºC to OD600 of 0.6 were 
harvested and resuspended in 500µl volume of SMMP buffer (Appendix). Lysozyme was 
added to a final concentration of 10mg/ml and incubated for 2 hours at 37ºC with gently 
agitation. The treated cells were then harvested and washed once by resuspending them 
gently in 500µl SMMP buffer and pelleted the second time. The washed protoplast was 
brought to 500µl volume with SMMP buffer. An amount of 1pg to 5µg of DNA in 7.75µl 
of TE buffer was mixed with equal volume of 2X SMM buffer (Appendix) in a sterile 
Eppendorf tube. 77.5µl of the protoplast suspension was added to the DNA, followed by 
the addition of 232µl of 40% PEG (w/v) solution (Appendix) and the contents of the tube 
gently mixed. After 2 min of exposure to PEG, 775µl of SMMP buffer was added to the 
mixture to dilute the PEG. Protoplast was recovered by centrifugation for 10 min and the 
resuspended in 200µl of SMMP buffer. The resuspended protoplast was incubated for 2 
hours at 30ºC to allow phenotypic expression carried by the plasmid. After incubation the 
suspension was spread on DM3 regeneration plates (Appendix) which were 
supplemented with 15µg/ml of chloramphenicol and incubated overnight at 37ºC. 
 
 
2.7.4 Electroporation of S. aureus 
 
S. aureus cells were prepared for electroporation by inoculating a fresh colony into 5ml 
of BHI broth and incubated overnight at 37ºC. The overnight culture was then diluted 
100X on BHI broth and grown at 37ºC until the OD600 was <0.5. The cells were washed 
twice in electroporation buffer (Appendix) at 4ºC. An aliquot of 100µl of the S. aureus 
cells was transferred into an Eppendorf tube and 5-10µl of DNA was added. This was 
mixed by bubbling air through and left to stand on ice for 10 min to allow diffusion. The 
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mixture was then transferred into a pre-chilled electroporation cuvette and electroporated 
(25µF, 2.0kV and 200Ω). BHI broth was added immediately to the electroporated cells 
and incubated for 1 hour at 37ºC for the expression of the antibiotic resistance markers. 
After incubation the cells were plated on BHI agar plates supplemented with an 
appropriate selectable marker and incubated for overnight. 
 
2.8 Preparation of DNA for sequencing 
 
DNA was prepared using the E. coli mini plasmid preparation method in 2.4.3. There 
were modifications done on this procedure. After the cell debris was precipitated and the 
supernatant collected into a new tube, the DNA was extracted by the phenol-chloroform 
extraction method in 2.5.1.4 to remove any protein and other cellular components that 
might be in the supernatant. The DNA was then precipitated with isopropanol as in 
2.5.1.2. After DNA had been prepared the concentration and purity of the DNA was 
analyzed on agarose gel. Sequencing performed by Inqaba Biotechnology Industries (Pty) 
Ltd 
 
2.9 Mutagenesis 
 
2.9.1 N-methyl-N´-nitro-N-nitrosoguanidine (NTG) mutagenesis 
 
A volume of 300µl of an overnight bacterial culture was microfuged for 30 seconds and 
the supernatant was discarded. The pellet was re-suspended in 1ml of Tris-Maleate buffer 
(pH 9) and washed twice in the same buffer. After washing, the pellet was re-suspended 
in 1ml of Tris-Maleate buffer where 50µl of NTG stock solution (1mg/ml) was added. 
Immediately after the addition of NTG solution the cells were microfuged for 30 seconds 
and the supernatant discarded. The cells were washed twice in Phosphate buffer (pH 7) 
because neutral pH completely inhibits the NTG reaction. The cells were inoculated into 
5ml of LB and grown overnight at 37ºC. A volume of 100µl of the grown culture was 
spread on selective media and further incubated for overnight at 37ºC. 
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2.9.2 Site-directed mutagenesis 
 
Numerous methods have been developed or exploited to mutate DNA. Initially all 
approaches focused on the generation of random mutations in chromosomal DNA such as 
those induced by X-rays and chemicals. While these methods of random mutagenesis 
provided a valuable tool for classical gene studies, they were limited by their inability to 
target the mutation to a specific gene or genetic element. Site-directed mutagenesis is 
widely used in the study of gene and protein functions. A Phusion
TM
 Site-Directed 
Mutagenesis Kit was used in this study. This is a PCR-base site-directed mutagenesis 
which uses two primers, one which is a mutagenic primer directed to the target site and 
the other one is non-mutagenic which aligns anywhere in the plasmid. 
 
2.10 Counter-selection for auxotrophic mutants 
 
A mutated culture from 2.9.1 grown overnight was washed 3× with 10× stock III buffer 
or sterile distilled water to remove traces of rich media. The washed cells were then 
resuspended in 1 ml of stock III buffer. It was then diluted 50× in Stock III buffer and 
grown until mid-log phase. Ampicillin was added to a concentration such that it does not 
kill the latent cell which should be the auxotrophs. After the addition of ampicillin the 
culture was grown overnight followed by diluting the culture to 10
-5
 and 100µl of the 
diluted culture was spread on LB agar plates. The plates were incubated overnight at 
37˚C. After incubation the developed colonies were patched on minimal media and rich 
media and grown incubated overnight. The colonies that grow on rich media but not on 
minimal media were identified as auxotrophic mutants. Their nutritional requirements 
were determined by patching the auxotrophic mutants in minimal media supplemented 
with different auxotrophic requirement.  
 
2.11 Rifampicin inactivation test 
 
A mutated culture from 2.9.1 which was rifampicin resistant was dilutes 100X in fresh 
LB and grown for 2 hours at 37ºC. After the 2 hours of growth rifampicin was added to a 
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final concentration of 20µg/ml and further incubated for overnight. Uninoculated LB was 
used as a control. LB agar plates with half the concentration of agar were used and were 
supplemented with 200µg/ml of streptomycin. ND3 (streptomycin resistant mutant) was 
used as an overlay organism by spreading it on the ½ LB agar plates supplemented with 
streptomycin. Once the overlay organism had dissolved properly in the plates wells were 
made by using the back of a Pasteur pipette. A volume of 80µl of the overnight culture 
was inoculated into the well made. The plates were kept at 4ºC for 4-6 hours to allow 
diffusion of the inoculated culture followed by incubation at 37ºC for overnight. After 
incubation the zones of inhibitions are measured.  
 
2.12 Plasmid curing 
 
B. subtilis 168 (pC194) was cured of its plasmid using EtBr. Cells were inoculated into 
5ml of LB and grown overnight without antibiotic. The overnight culture was diluted 
100× in fresh LB and different concentrations of EtBr were used (0.01, 0.02 and 0.03%). 
A no EtBr control was used. The cells were allowed to grow overnight followed by 
another 100× dilution in LB without a selective agent and grown overnight. The 
overnight culture was diluted to the 10
-5
 spread on LA plate with no selective agent and 
incubated for overnight. The colonies were observed and they were patched on LA plate 
supplemented with 15µg/ml of chloramphenicol (Cm) and also on LA plate with no 
antibiotic. The plates were incubated at 37˚C for overnight and the colonies that could not 
grow on the LA plate with Cm were successfully cured of the plasmid. 
 
Table 2.1: Internet sequence analysis programs used 
Program Web address 
BLAST http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi 
NEBcutter http://tools.neb.com/BEBcutter2/index.php 
FASTA http://fasta.bioch.virginia.edu/fasta_www2/fasta_www.cgi 
NEBcutter (silent 
 mutagenesis) 
http://tools.neb.com/NEBcutter2/silmutlist.php 
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3. RESULTS  
 
3.1 Bacillus-Staphylococcus-E. coli shuttle vector construction  
 
Plasmid pEcoR251 has a BamHI site downstream of the EcoRI endonuclease gene 
(figure A6.5) and this site does not fall within any known important regions of the 
plasmid. Plasmid pC194 has an XhoII site which is just after the chloramphenicol 
resistance determinant (figure A6.1) and does not interfere with the expression of this 
gene. Plasmid pC194 was digested with XhoII and pEcoR251 was digested with BamHI 
and these were ligated together using the complementary single stranded ends to give 
pNDW1 (Figure 3.2). This construct should be maintained in B. subtilis and E. coli since 
it had the origin of replication for Gram positives and Gram negatives. It was transformed 
into E. coli λ lysogen and a non-lysogen to determine the functioning of the suicide gene. 
Plasmid pEcoR251 was used as a control because it was desired that the construct 
function in a similar manner due to the suicide gene. Transformants were obtained in the 
lysogen but not non-lysogen confirming that EcoRI was functional. Plasmid DNA from 
these transformants was digested with informative restriction enzymes and the size 
expected was confirmed and the plasmid orientation determined (Figure 3.1).   
 
         1    2    3    4    5   6   7   8   9   10 
 
 
 
 
 
 
 
 
 
Figure 3.1:  Restriction digests of pNDW1. Lane 1 and 10 are DNA markers, 2 is 
undigested, 3 is PstI, 4  SwaI, 5 StuI, 6 HindIII, 7 BglII, 8 EcoRI and 9 SfuI. 
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Figure 3.2: Restriction map of plasmid pNDW1. 
 
3.1.1 Transformation of B. subtilis with pNDW1 
 
Attempts were made to transform pNDW1 into B. subtilis IA3 but these were 
unsuccessful. To investigate why, two new constructs were made by joining pC194 
(XhoII) with pEcoR251 (BglII): pNDW2 and the other one by joining pC194 (HindIII) 
with pEcoR251 (HindIII): pNDW3. Both constructs had the suicide gene interrupted and 
in contrast to pNDW1 transformed a non-lysogen and a lysogen of E. coli with similar 
frequency, behaving in the same manner as pDA71* used as a control. Digestions of 
miniprep DNA of these constructs were done to confirm their sizes and their orientations 
(Figure 3.3 (B)). Plasmid pNDW1 was used to clone a PstI 1.8Kb fragment isolated from 
a Norcadioform brasiliensis PstI library, encodes the glucoslytransferase responsible for 
rifampicin resistance in Norcadioforms, into the PstI site on the suicide gene. This 
construct was named pNDW4 and mini DNA preparations of this construct were done to 
confirm the presence of an insert (Figure 3.3 (A)). Plasmids pNDW2, pNDW3 and 
pNDW4 were successfully transformed into B. subtilis confirming that the failure with 
pNDW1 was not because the construct was unable to replicate but because the suicide 
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gene was expressed in that organism. Restriction maps of pNDW2 and pNDW3 are 
shown in Figure 3.4. 
 
                      A                              B 
     1      2      3    4      5      6    7      8                        1    2   3   4   5   6    7    8   9  10  11 
 
   
 
 
 
 
 
 
 
 
 
 
Figure 3.3: (A) Lanes 2-7: pNDW4 digested with Pst I to release the inserts which are 
the lower bands. Lanes 1 and 8 are DNA markers. (B):  Lanes 2-5: pNDW2, lane 2 is 
undigested, lane 3 is HindIII digest, lane 4 PstI digest and lane 5 is StuI digest. Lanes 8-
10 is pNDW3, lane 8 is undigested, lane 9 is HindIII digest, lane 10 is PstI digest and 
lane 10 is StuI digest. Lanes 1 and 7 are DNA markers. 
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Figure 3.4: Plasmid map of constructs indicating the way in which the suicide gene was 
disrupted, (A) Restriction map of plasmid pNDW2, (B) Restriction map of plasmid 
pNDW3.   
 
3.1.2 Transformation of S. aureus with pNDW1  
 
Transformation of S. aureus by pNDW1 using electroporation was successful using the 
conditions of Wada and Watanabe (1998). pC194 was used as a control since this 
plasmid was originally isolated from S. aureus. Transformants were observed with both 
but for pNDW1 the efficiency was very low. Transformants were not expected for 
pNDW1 if the suicide gene was expressed in this organism. DNA preparation of S. 
aureus transformants was re-transformed back into E. coli λ lysogen and non-lysogen to 
check the status of the suicide gene. Transformants were only observed on the λ lysogen 
showing that the suicide gene is functional. DNA preparation from 20 transformants was 
done and digested with PstI to check the size of the plasmid (Figure 3.5)  
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Figure 3.5: Plasmid preparation of pNDW1 from λ lysogen. (A) 10 of the 20 
transformants. Lane 1 and 12 are molecular weight markers. Lanes 2-11 pNDW1 from 
different transformants digested with PstI. (B) The other 10 transformants. Lanes 1 and 
12 are molecular weight markers. Lanes 2-11 pNDW1 from transformants digested with 
PstI. 
                                                     1     2     3   4     5     6    7    8    
     
 
 
 
 
 
 
 
 
 
Figure 3.6:  pNDW1 from S. aureus. Lane 1 is molecular weight marker. Lane 2 is 
undigested, lane 3 is EcoRI, lane 4 is StuI, lane 5 is HindIII, lane 6 is SwaI, lane 7 is SpeI 
and lane 8 is PstI. 
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DNA from the clone of Figure 3.5 (B) lane 11 was further digested to compare this 
pNDW1 to the pNDW1 used to transform S. aureus (figure 3.6). Since the two are 
indistinguishable I concluded that EcoRI is not expressed in S. aureus, in contrast to B. 
subtilis.  
 
3.2 Introduction of new sites into EcoRI 
 
Introduction of additional restriction sites in the suicide gene of pNDW1 would increase 
its versatility in genomic library construction and subcloning. Candidate restriction sites 
were chosen using the following criteria:  
1) The enzyme has a 6 bp palindromic recognition sequence.  
2) The restriction site should be unique in the vector. 
3) The site should towards the 5 ′ end of EcoRI (first 600bp). 
4) The enzyme should generate cohesive rather than blunt ends for better ligation.  
The Silent Mutagenesis Program on NEBcutter website was used to determine which 
restriction sites can be introduced and where mutation should be made on the suicide 
gene sequence. This program gives possible mutations that can be introduced into the 
sequence without changing the amino acid sequence of the protein. All possible 
mutations were analyzed and 11 candidates identified. Table 3.1 lists these. The bases 
that are coloured and underlined red are the mutated bases.  
 
TABLE 3.1: Candidate Additional Restriction Sites in EcoRI 
 
Enzyme Specificity Position Mutated bases underlined 
 
AvrII C CTAG G 228 211 AAAAAAATTGACCCTGACCTAGG 
CGGTACTTTATTTGTTTCA 252 
BclI T GATC A 396 379 TTAGTTGGGAAAAGAGGTGATCA 
AGATTTAATGGCTGCTGGT 420 
ClaI AT CG AT 23 40TCTAATAAAAAACAGTCAAATCGAT 
TAACTGAACAACATAAG  45 
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ClaI AT CG AT 217 199 AATGAAGCTTTAAAAAAAATCGAT 
CCTGATCTTGGCGGTACT 240 
ClaI AT CG AT 258 241 TTATTTGTTTCAAATTCATCGAT 
CAAACCTGATGGTGGAATT 282 
SpeI A CTAG T 120 103 GTTGGTGAGGTTTCAAAACTAGT 
AAAGAAAGCTCTTAGCAAC 144 
SpeI A CTAG T 321 304 GGTGAATGGAGAGTTGTACTAGT 
TGCTGAAGCCAAACACCAA 345 
XbaI T CTAG A 504 487 TTTCCTTACGTCCTTTTTCTAGA 
GGGGTCTAACTTTTTAACA 528 
XhoI C TCGA G 255 238 ACTTTATTTGTTTCAAACTCGAG 
CATCAAACCTGATGGTGGA 279 
XhoI C TCGA G 505 487 TTTCCTTACGTCCTTTTCCTCGAG 
GGGTCTAACTTTTTAACA 528 
 
SpeI is present in pC194 so was excluded. Genomic DNA of B. polymyxa was digested 
with these restriction enzymes to see which might be suitable in cloning Bacillus 
genomic DNA. Figure 3.7 shows the gel image of this.  
 
             1      2       3      4      5       6     7      8 
 
 
 
 
 
 
 
 
 
Figure 3.7: B. polymyxa genomic DNA, lane: 2 undigested; 3-8 digested with: 3 ClaI, 4 
XhoI, 5 AvrII, 6 SalI, 7 PstI, and 8 XbaI. 
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These results (figure 3.7) were useful in narrowing down which restriction site should be 
introduced into pNDW1 suicide gene. ClaI digested the genomic DNA very frequently 
and so was unlikely to be useful when creating a genomic library because it is preferable 
to have the entire open reading frame of a particular gene rather than having pieces of the 
gene scattered all over the library. Also ClaI partial digestions of Bacillus genomic DNA 
might be inserted into the SfuI site already present in the suicide gene. AvrII, SalI and 
XhoI were possible candidates as they digested the genomic DNA generating large 
fragments. PstI was used as a control because it has been observed that PstI would be a 
suitable enzyme to create a genomic library of B. polymyxa genomic DNA (figure 3.37). 
XbaI seemed to digest genomic DNA comparably to PstI so I decided this would be the 
best choice.  
 
3.2.1 Introduction of an XbaI site in pNDW1 
 
To empirically confirm that XbaI sites were absent in pC194 and pEcoR251 (as predicted 
from published sequences) they were digested with this enzyme. As shown in Figure 3.8. 
XbaI did not cut either plasmid.  
 
         A      B 
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Figure 3.8:(A) Lane 1 is the molecular weight markers, lane 2 is pC194 undigested, lane 
3 is pC194 digested with SpeI and lane 4 is pC194 digested with XbaI. (B) Lanes 1 and 5 
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are molecular weight markers, lane 2 pEcoR251 undigested, lane 3 PstI digest and lane 4 
is XbaI digest. 
 
Having concluded that XbaI was the best restriction site to introduce into the pNDW1 
suicide gene a site-directed mutagenesis kit was used to introduce the mutation required. 
The following primers were used  
 
5´-TACGTCCTTTTTCTAGAGGGGTCTA-3´ and a reverse primer  
5´-AGGAAAGTGGGCTCTCAGAGAGCA-3´.  
 
 
TABLE 3.2 Mutagenic reaction mixture for XbaI site 
_______________________________________________________________________ 
Components   Volume/50µl reaction  Final concentration 
Sterile dH2O    36.7µl 
5X Phusion HF buffer  10µl     1X 
10mM dNTPs    1µl     200µM each 
Mutagenic primer   0.25µl     0.5µM 
Reverse primer   0.25µl     0.5µM 
DNA template (0.4ng/µl)  1.25µl     10pg 
Phusion hot start DNA 
 Polymerase (2U/µl)   0.5µl     0.02U/µl 
 
 
TABLE 3.3 Cycling conditions for mutagenic reaction for XbaI site 
________________________________________________________________________ 
Cycle step  Temperature  Time  Number of cycles 
Initial  
Denaturation  98ºC   30 Sec   1 
 
Denaturation  98ºC   10 sec 
 37 
Annealing  67ºC   30 sec   25 
Extension  72ºC   4 min 
Final  
Extension  72ºC   5 min 
 
 
The PCR reaction was successful because a band of amplification was observed 
corresponding to the template size (pNDW1) (Figure 3.9). A no template control was 
used. 
 
    1         2        3 
 
                                                   
 
 
 
 
 
 
 
 
 
Figure 3.9: 5µl of the PCR product ran on 0.6% agarose gel. Lane 1 is Molecular weight 
marker, Lane 2 is the PCR product and lane 3 is the control reaction. 
 
The PCR product was a linear plasmid molecule therefore it was circularized with Quick 
T4 DNA ligase provided in the kit. The circularized plasmid was then transformed into E. 
coli MM294-4 λ lysogen. DNA mini preparation of 10 transformants was done and 
digested with XbaI to screen for plasmid which had acquired the XbaI site. A single clone 
had the XbaI site (Figure 3.10 lane 3). To confirm that the plasmid was pNDW1 with a 
new restriction site XbaI, restriction digestions were done on the DNA in lane 3 Figure 
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3.10. Figure 3.11 presents the gel image of the digestions and confirmed that the XbaI 
restriction site was introduced on pNDW1.  
 
                                         1   2    3   4   5   6   7   8  9  10 11 12 
 
 
 
 
 
 
 
 
 
 
Figure 3.10:  Lanes 1and 12 are molecular weight markers, lanes 2-11 are the DNA 
preparations digested with XbaI. 
 
                                           1       2     3       4      5      6       7 
 
 
 
 
 
 
 
 
 
 
Figure 3.11:  Lane 1 is the molecular weight marker, lane 2 is the undigested DNA, lane 
3 is SpeI digest, lane 4 is PstI digest, lane 5 is HindIII digest, lane 6 is EcoRI digest and 
lane 7 is XbaI digest. 
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All of the enzymes used to digest the DNA preparation linearized the plasmid except for 
HindIII which should give two fragments. Figure 3.11 confirmed that the XbaI restriction 
site was introduced in plasmid pNDW1 which was named pNDW5. The other restriction 
enzymes used indicated that XbaI linearized the plasmid as did the other enzymes. To 
check if the suicide gene was still functional after the introduction of the new site, 
pNDW5 was transformed into E. coli MM294-4 λ lysogen and E. coli MM294-4 non-
lysogen. pDA71* and pNDW1 were controls.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: E. coli transformed with pNDW1, pNDW5 and pDA71* showing the 
behavior of pNDW5 in relation to pNDW1 and pDA71*. 
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The function of the suicide gene was maintained, as shown by the transformants on plate 
C but not A (Figure 3.12). DNA preparations of pNDW5 on plate C (Figure 3.12) were 
done and the DNA was digested with XbaI to check if the transformants have plasmid 
pNDW5 (Figure 3.14). Figure 3.13 is a map of pNDW5 showing the new XbaI site 
between restriction sites BglII and PstI on the EcoRI endonuclease gene.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Restriction map of plasmid pNDW5. 
 
          1  2    3   4   5   6    7   8  9  10  11  12     
 
 
 
 
 
 
 
 
 
Figure 3.14: Plasmid DNA of randomly picked transformants digested with XbaI. Lanes 
1 and 12 are molecular weight markers. Lanes 2-11 are DNA digests. 
 41 
DNA of clones from plate C Figure 3.12 was digested with XbaI and was also digested 
with XbaI. Figure 3.15 shows the gel image of the digestions. This confirmed that the 
site was present in pNDW5 but not its parent pNDW1.  
 
                1   2    3   4    5    6    7   8    9   10  11 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: pNDW1 and pNDW5 digested with XbaI.  Lane 1and 11 are molecular 
weight markers. Lanes 2 and 4 is undigested pNDW1 and pNDW5, respectively. Lanes 3, 
6 and 8 are pNDW1 digested with XbaI. Lanes 5, 7 and 9 are pNDW5 digested with 
XbaI. 
 
pNDW5 was double digested with BglII and PstI to cut out the 175bp fragment that had 
incorporated the XbaI restriction site which was cloned into pUC19 pre-incubated with 
calf intestinal phosphatase via the BamHI and PstI restriction sites. pUC19 was used 
because the multiple cloning sites is flanked with sequencing primers. This construct was 
sent to Inqaba Biotechnical industries (Pty) Ltd for sequencing to confirm the presence of 
the XbaI site. Aligning the mutated and unmutated sequences using the Basic local 
alignment search tool (BLAST) showed the predicted CT→ TC base change (red and 
underlined)  
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AGAATATATCAGAGATAGCGAATTTTATGCTCTCTGAGAGCCACTTTCCTTACGTCCTTT  60                         
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
       AGAATATATCAGAGATAGCGAATTTTATGCTCTCTGAGAGCCACTTTCCTTACGTCCTTT  62 
  
 
       TTCTAGAGGGGTCTAACTTTTTAACAGAAAATATCTCAATAACAAGACCAGATGGAAGGG  120            
|  ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
       TCTTAGAGGGGTCTAACTTTTTAACAGAAAATATCTCAATAACAAGACCAGATGGAAGGG  122 
 
      TTGTTAATCTTGAGTATAATTCTGGTATATTAAATAGGTTAGATCGACTAA  171 
      ||||||||||||||||||||||||||||||||||||||||||||||||||| 
      TTGTTAATCTTGAGTATAATTCTGGTATATTAAATAGGTTAGATCGACTAA  173 
 
Figure 3.16:  The sequence alignments of the BglII-PstI fragment of both the mutant 
pNDW5 (top sequence) and its parent pNDW1 (bottom sequence). 
 
Genomic DNA of B. polymyxa digested with XbaI was ligated to XbaI-digested pNDW5 
and transformed into E. coli MM294-4. Minipreps of 10 randomly chosen transformants 
were digested with XbaI to determine if they contain the recombinant pNDW5 plasmid. 
Figure 3.17 shows the presence of inserts of various sizes as one would expect. 
 
 1   2   3   4   5   6   7   8   9   10 11  12 
 
 
 
 
 
 
 
 
 
Figure 3.17: pNDW5 clones digested with XbaI to release inserts from the plasmid. 
Lanes 1 and 12 are molecular weight markers. Lanes 2-11 are plasmid DNA (pNDW5 
clones) from transformants randomly chosen and digested with XbaI.  
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Different clones of pNDW5 (figure 3.17) did not transform S. aureus or B. subtilis but 
when a pool of clones was used transformants were observed in both hosts. This suggests 
that the individual clones that were used to transform S. aureus and B. subtilis had big 
fragment sizes (more than 1.5Kb) that could have resulted in low transformation 
efficiency and these host strains might have a restriction modification system resulting in 
no transformants.   
 
3.2.2 Introduction of more new sites  
 
ClaI, AvrII and XhoI were other candidate restriction sites to be introduced as described 
in section 3.2. However digesting parent plasmids pC194 and pEcoR251 with ClaI 
indicated that pC194 had two sites for this enzyme (Figure 3.18). AvrII, XbaI and SpeI 
are isocaudomers (i.e. generate identical single-strand ends). XhoI was selected as it cut 
B. polymyxa genomic DNA generating mainly large fragments (Figure 3.7) and digestion 
of pC194 and pEcoR251 confirmed absence of the XhoI site in both (Figure 3.18).   
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Figure 3.18: pEcoR251 and pC194 digestions. Lanes 1 and 5 are molecular weight 
markers. Lane 2 is undigested pEcoR251, lane 3 is ClaI digested pEcoR251 and lane 4 is 
XhoI digested pEcoR251. Lane 6 is undigested pC194, lane 7 is ClaI digested pC194 and 
lane 7 is XhoI digested pC194. 
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Introduction of the XhoI site was done by site-directed mutagenesis using the following 
primers: Mutagenic primer 5′-TTGTTTCAAACTCGAGCATCAAACCT-3′ and reverse 
primer 5′-ATAAAGTACCGCCAAGATCAGGGTCA-3′.  
 
TABLE 3.4 Mutagenic reaction mixture for XhoI site 
_______________________________________________________________________ 
Components   Volume/50µl reaction  Final concentration 
Sterile dH2O    37.3µl 
5X Phusion HF buffer  10µl     1X 
10mM dNTPs    1µl     200µM each 
Mutagenic primer   0.25µl     0.5µM 
Reverse primer   0.25µl     0.5µM 
DNA template (0.7ng/µl)  0.7µl     10pg 
Phusion hot start DNA 
 Polymerase (2U/µl)   0.5µl     0.02U/µl 
 
TABLE 3.5 Cycling conditions for mutagenic reaction for XhoI site 
________________________________________________________________________ 
Cycle step  Temperature  Time  Number of cycles 
Initial  
Denaturation  98ºC   30 Sec   1 
 
Denaturation  98ºC   10 sec 
Annealing  67ºC   30 sec   25 
Extension  72ºC   4 min 
Final  
Extension  72ºC   5 min 
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A PCR reaction was performed using the reaction and cycling conditions in tables 3.4 
and 3.5 above. Five micro liters of the PCR product was ran on a 0.4% agarose gel to 
check if amplification of the template had occurred (Figure 3.19). 
                                                 1        2        3      4 
 
 
 
 
 
 
 
 
Figure 3.19: PCR product ran on 0.4% agarose gel. Lane 1 is the molecular weight 
marker, lane 2 is the 5µl of the DNA template digested with XbaI, lane 3 is 5µl of the 
PCR product and lane 4 is the PCR control with no DNA template. 
 
The PCR product was ligated with T4 DNA ligase (Fermentas) and introduced into E. 
coli λ lysogen. Ten transformants were chosen and DNA digested with XhoI (Figure 
3.20).                      
                                1   2   3   4    5   6    7   8   9  10 11  12 
                         
 
 
 
 
 
 
 
 
Figure 3.20: DNA preparations digested with XhoI. Lanes 1 and 12 are molecular weight 
markers. Lanes 2-11 is the DNA preparation digested with XhoI.  
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Each of these DNAs was introduced into E. coli λ lysogen and E. coli non-lysogen to 
check the function of the suicide gene. Only DNAs from lanes 2, 3 and 11 indicated that 
the suicide gene was still functional as indicated by the presence of transformants on E. 
coli λ lysogen. DNA preparations for 16 transformants of the DNAs 2, 3 and 11 were 
selected from each plate and labeled 1-16. The DNA preparations were digested with 
XhoI and run on 0.6% agarose gel. 
                                 A                                                                 B 
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Figure 3.21: DNA preparations 1-16 digested with XhoI. (A) lane 1 is molecular weight 
marker and lanes 2-9 is DNA 1-8, respectively. (B) Lane 1 is molecular weight marker 
and lanes 2-9 are DNA 9-16, respectively. 
 
DNA of the clone in lane 8 (Figure 3.21 A), named pNDW7, and from lane 2 (Figure 
3.21 B), named pNDW8 were digested with selected restriction enzymes. Plasmid 
pNDW7 had similar restriction pattern to pNDW5 in figure 3.11 but pNDW8 had 
different restriction digestion pattern because when digested with HindIII it indicating a 
partial digest.  
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Figure 3.22: Restriction digestions of pNDW7 and pNDW8.  (A) Is pNDW7. Lane 1 is 
molecular weight marker. Lane 2 is undigested DNA, lane 3 is XhoI digest, lane 4 is StuI 
digest, lane 5 is HindIII digest, lane 6 is XbaI digest and lane 7 is EcoRI digest. (B) Is 
pNDW8.  Lane 1 is molecular weight marker. Lane 2 is undigested DNA, lane 3 is XhoI 
digest, lane 4 is StuI digest, lane 5 is HindIII digest, lane 6 is XbaI digest and lane 7 is 
EcoRI digest. 
 
To check if pNDW7 has a functional suicide gene, it was transformed into E. coli λ 
lysogen and E. coli non-lysogen. Controls used were pDA71* and pNDW5. Figure 3.23 
indicated that transformants were observed on lambda lysogen (image B) not on a non-
lysogen (image C) confirming this was so.  Figure 3.25 is the plasmid map of pNDW7 
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Figure 3.23: Transformation plates indicating the behavior of pNDW7 on a lysogen and 
a non-lysogen. Image A and B is pDA71* in non-lysogen (A) and in λ lysogen (B). 
Image C and D is pNDW7 on a non-lysogen (D) and on a lysogen (C). Image E and F is 
pNDW5 on lysogen (E) and on a non-lysogen (F). 
 
To confirm the XhoI site was specific to pNDW7, DNA preparations from plate C figure 
3.23 were digested with XhoI and pNDW5 was also digested with XhoI (Figure 3.24). 
A B 
C D 
E 
F 
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Figure 3.24: Digestions of pNDW5 and pNDW7. Lane 1 is the molecular weight marker. 
Lane 2 is pNDW5 undigested, lane 3 is pNDW7 undigested, lane 4 is pNDW5 digested 
with XhoI, lane 5 is pNDW7 digested with XhoI. Lane 6 is pNDW5 digested with XhoI, 
lane 7 is pNDW7 digested with XhoI, lane 8 is pNDW5 digested with XhoI and lane 9 is 
pNDW7 is digested with XhoI.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.25: Restriction map of plasmid pNDW7. 
 
B. polymyxa genomic DNA was digested with XhoI and ligated into pNDW7 digested 
with the same enzyme and transformed into E. coli MM294-4: surprisingly, no colonies 
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were observed. Genomic DNA of Streptomyces pseudogriseolus was then used and was 
digested with XhoI (Figure 3.26). This genomic DNA was cloned into XhoI pNDW7 
digests and transformed into E. coli MM294-4. Colonies were observed and their 
plasmids screened for inserts and indicated that genomic DNA digested with XhoI can be 
cloned into the XhoI site of pNDW7 (Figure 3.27). 
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Figure 3.26: Streptomyces pseudogriseolus genomic DNA. Lane 1 is molecular weight 
marker, lane 2 is genomic DNA undigested and lane 3 is genomic DNA digested with 
XhoI. 
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Figure 3.27: DNA preparations of transformants digested with XhoI. Lane 1 and 12 are 
molecular weight markers. Lanes 2-10 is pNDW7 clones digested with XhoI. 
 
The HindIII-BglII fragment from pNDW7 was cloned into pUC19 treated with alkaline 
phosphatase via the HindIII and BamHI sites. Sequencing confirmed the presence of an 
XhoI site at the expected position but in addition there was a three base deletion (figure 
3.28). This is in-frame and predicted to result in a valine residue deletion. However the 
endonuclease activity of the EcoRI endonuclease gene was intact.  
 
AAAAATTGACCCTGATCTTGGCGGTACTTTATTT---TCAAACTCGAGCATCAAACCTGA  57 
||||||||||||||||||||||||||||||||||   ||||| || |||||||||||||| 
AAAAATTGACCCTGATCTTGGCGGTACTTTATTTGTTTCAAATTCCAGCATCAAACCTGA  63 
 
TGGTGGAATTGTAGAGGTCAAAGATGATTATGGTGAATGGAGAGTTGTACTTGTTGCTGA  117 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
TGGTGGAATTGTAGAGGTCAAAGATGATTATGGTGAATGGAGAGTTGTACTTGTTGCTGA  123 
 
Figure 3.28: Sequence alignment of the HindIII-BglII fragments of the mutated and a 
non mutated sequence of the suicide gene. The top sequence is the mutated sequence and 
the bottom sequence is the non-mutated sequence. 
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The HindIII-BglII fragment of the original EcoRI endonuclease gene from plasmid 
pEcoR251 was sent for sequencing to check if the deletion was present prior to the 
mutagenesis or not.  
 
AAAAAATTGACCCTGATCTTGGCGGTACTTTATTTGTTTCAAATTCCAGCATCAAACCTG  67           
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
AAAAAATTGACCCTGATCTTGGCGGTACTTTATTTGTTTCAAATTCCAGCATCAAACCTG  69 
 
ATGGTGGAATTGTAGAGGTCAAAGATGATTATGGTGAATGGAGAGTTGTACTTGTTGCTG  127            
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ATGGTGGAATTGTAGAGGTCAAAGATGATTATGGTGAATGGAGAGTTGTACTTGTTGCTG  129 
 
AAGCCAAACACCAAGGTAAAGATATTATAAATATAAGGAATGGTTTGTTAGTTGGGAAAA  187            
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
AAGCCAAACACCAAGGTAAAGATATTATAAATATAAGGAATGGTTTGTTAGTTGGGAAAA  189 
 
GAGGAGATCAAGATTTAATGGCTGCTGGTAATGCTATCGAA  228 
||||||||||||||||||||||||||||||||||||||||| 
GAGGAGATCAAGATTTAATGGCTGCTGGTAATGCTATCGAA  230 
 
 
Figure 3.29: Sequence alignment of the original EcoRI HindIII-BglII fragment aligned to 
the known sequence of EcoRI endonuclease gene. Top sequence (from pEcoR251) and 
bottom sequence (known sequence). 
 
A deletion was not present in the EcoRI gene from pEcoR251 (Figure 3.29). The deletion 
apparently arose during the mutagenesis procedure. The mutated EcoRI gene sequence 
was put on the NEBcutter website to confirm the presence of newly introduced sites. The 
output from the website indicated that the new sites were (figure 3.30).                      
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                                                                        A 
 
 
 
 
 
 
 
 
 
 
                                                      
        B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30: Predictions of restriction sites on original and mutated EcoRI endonuclease 
gene. (A) Is the original EcoRI sequence. (B) Is the mutated EcoRI sequence, the blue 
box indicates the new restriction sites predicted by NEBcutter program.  
 54 
3.2.3 Introduction of the XbaI restriction site into pDA71 
 
Plasmid pDA71 is an 8.8Kb E. coli-Rhodococcus shuttle vector which has an ampicillin 
resistant determinant expressed in Gram-negatives and a chloramphenicol resistant 
determinant expressed in Gram-positives; it has been successfully used to clone more 
than thirty genes of medical or bioremediative interest (Dabbs et al., 1995). Introduction 
of XbaI restriction sites in pDA71 allows the use of SpeI, NheI and AvrII restriction sites 
to construct genomic libraries.  To introduce the XbaI restriction site into it the 175 bp 
BglII-PstI fragment from pNDW5 was used to substituted with the same fragment from 
pDA71. Plasmid pDA71 was double digested with BglII and PstI and phosphatased. 
Ligations were transformed into E. coli λ lysogen. DNA minipreps were done of 10 
transformants were digested with XbaI. Figure 3.31 shows the gel image of the 
transformants. 
 
                                         1    2    3   4    5    6    7    8    9  10  11  12 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.31: DNA preparations digested with XbaI to screen for the presence of XbaI site 
in pDA71. Lane 1 and 12 are molecular weight markers. Lanes 2-11 are DNA 
preparations digested with XbaI. 
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The DNA preparation on lane 3 Figure 3.31 was further digested with a couple of 
restriction enzymes in order to determine whether it is a correct plasmid (Figure 3.32) 
and was named pDA71-1. StuI digestion result indicated that it is a correct plasmid 
because of the presence of two StuI site giving one smaller fragment and one large 
fragment. 
 
                                              1     2       3    4    5    6     7     8 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32: Digestion of the pDA71-1 that contains XbaI. Lanes 1 and 8 are molecular 
weight markers; lane 2 is undigested pDA71-1, lane 3 is HindIII digest, lane 4 is BglII 
digest, lane 5 is SfuI digest, lane 6 is XbaI digest and lane 7 is StuI digest. 
 
pDA71-1 was transformed into E. coli λ lysogen and non-lysogen together with pNDW5, 
pDA71* to determine if the suicide gene was functional (Figure 3.33).  
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Figure 3.33: Transformation plates indicating the behavior of pDA71-1. 
 
The plates in figure 3.33 indicates that the suicide gene is functional hence the 
transformants on a lysogen. DNA was inserted into the XbaI site of pDA71-1 to 
determine if this site is useful in cloning DNA and can be released from the plasmid by 
digestion with XbaI. Plasmid map of pDA71-1 is presented in Figure 3.35. Genomic 
DNA of B. polymyxa was digested with XbaI and ligated into XbaI digested pDA71-1. 
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This was transformed into E. coli MM294, selected for ampicillin resistance, and 
transformants screened for the presence of the plasmid that has an insert (Figure 3.34).  
                                               1         2       3        4      5       6 
                                     
 
 
 
 
 
 
 
 
 
 
Figure 3.34: plasmid DNA of pDA71-1 clones digested with XbaI to release cloned 
DNA. Lane 1 is the molecular weight marker and lanes 2-6 are plasmid DNA with inserts 
released. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.35: Restriction map of plasmid pDA71-1. 
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3.2.4 Introduction of XhoI site into plasmid pEcoR251  
 
Plasmid pEcoR251 is 3.3 kb in size and is useful in the construction of E. coli positive 
selection shuttle vectors. It can provide a Gram-negative replicon for the shuttle vector 
and a positive selection gene. The HindIII-BglII fragment of the plasmid pNDW7 
(Figure 3.25) was used as a source of the XhoI site. Plasmid pEcoR251 was digested 
with the same enzymes and phosphatased. The HindIII-BglII fragment from pNDW7 was 
used to substitute a HindIII-BglII fragment of pEcoR251. Transformants minipreps were 
screened for the presence of an XhoI site. Eight transformants were tested and all of them 
were digested with XhoI indicating that the site was present (figure 3.36). Four of the 
DNA preparations of the 8 transformants were transformed into E. coli λ lysogen and a 
non lysogen to check which of these preparations had a functional suicide gene.   
 
 1   2   3    4    5    6    7    8    9 
 
 
 
 
 
 
 
 
 
 
Figure 3.36: DNA preparation of transformants digested with XhoI. Lane 1 is molecular 
weight marker. Lanes 2-9 is XhoI digests. 
 
Only DNA from lane 2 (Figure 3.36) had a functional suicide gene and was further 
digested with restriction enzymes to confirm if it is pEcoR251 with a new site. Figure 
3.37 presents the gel image of the digestions. 
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Figure 3.37: pEcoR251 with the new restriction site. Lanes 1 and 8 are molecular weight 
markers. Lane 2 is undigested, lane 3 is HindIII digest, lane 4 is BglII digest, lane 5 is 
BamHI-EcoRI digest, lane 6 is SfuI digest and lane 7 is XhoI digest. 
 
This plasmid was then transformed into E. coli λ lysogen and a non-lysogen to check the 
function of the suicide gene. Plasmids pDA71* and pEcoR251 (original) were used as 
controls. Figure 3.38 represents the behavior of the modified pEcoR251 which was 
named pEcoR251-1. 
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Figure 3.38: Transformants indicating the behavior of the modified pEcoR251. Image A 
and B is pEcoR251 on a non-lysogen and a lysogen, respectively. Image C and D is 
pDA71* on a non-lysogen and a lysogen, respectively. Image E and F is pEcoR251-1 on 
a non-lysogen and a lysogen, respectively.  
 
 
A B 
C D 
E 
F 
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3.3 Inactivation of rifampicin by Bacillus species 
 
Preliminary experiments were done to confirm that one of the shuttle vectors I had made 
could be used to clone Bacillus genes. Members of this genus were shown by Dabbs et al. 
(1995) to have the ability to inactivate rifampicin. B. polymyxa was a species that can 
inactivate rifampicin by glycosylation. Initially this strain was going to be used to screen 
for this inactivation gene then the focus of work changed and it was used for cloning by 
complementation in an auxotrophic mutants of B. subtilis.  
 
3.4 Genomic library construction 
   
A genomic library was constructed using plasmid pNDW1. This was done to check if this 
pNDW1 can be useful in the construction of a genomic library. The library was going to 
be used to check if there was any fragment of B. polymyxa genomic DNA that can 
complement the auxotrophic mutants, the KIT strains, in section 2.1. Genomic DNA of 
B. polymyxa was digested with restriction endonucleases to determine which restriction 
endonuclease will be used to construct a genomic library.  
 
       1    2    3     4    5    6    7    8    9 
 
 
 
 
 
 
 
 
 
Figure 3.39:  Genomic DNA digestions. Lane 1 is molecular weight marker, lane 2 is 
undigested DNA, lane 3 is BglII digest, lane 4 is HindIII digest, lane 5 is PstI digest, lane 
6 is NarI digest, lane 7 is ClaI digest, lane 8 is SfuI digest and lane 9 is BclI digest.  
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The restriction endonuclease chose was the one that does not digest the genomic DNA 
too frequently as that could lead to pieces of gene scattered all over a genomic library. It 
is desirable to have a restriction endonuclease that does not cut genomic DNA frequently 
because the possibility of getting the entire gene in a plasmid is high. Figure 3.39 
indicates that BglII does not cut the genomic DNA as there is no difference between the 
BglII digest and the undigested genomic DNA. HindIII, ClaI, SfuI and BclI cut the 
genomic DNA too frequently with that they were not used for the library construction. 
PstI and NarI were found chosen as they do not digest the genomic DNA too frequently. 
PstI was of best choice because a PstI site is present in pNDW1 and it would be easy to 
excise the fragment cloned into that site by simple digestion with PstI. 
 
3.4.1 Vector calibration  
 
The amount of vector to be used for library construction was determined. This was to 
determine the minimum amount required to produce the least amount of transformants 
caused by mutation and plasmid re-ligating to itself. An aliquot of 200µl was digested 
with PstI and after digestion the DNA was purified by phenol-chloroform extraction. 
Ligation reaction were set up with different amount of plasmid, 2µl of T4 DNA ligase 
buffer and 1µl of T4 DNA ligase was added. The volume was adjusted to 20µl and was 
incubated at 22ºC for 16-22 hours. The E. coli MM294-4 was then transformed with the 
ligation mixture. The amount of vector which gave the least amount transformants was 
chosen. 
 
3.4.2 Genomic DNA calibration 
 
The amount of genomic DNA to be used with the plasmid amount determined above, was 
also determined by first digesting the genomic DNA with PstI and setting up ligations 
reaction to 20µl using 2µl of T4 DNA ligase buffer and 1µl of T4 DNA ligase. The only 
difference in this part was that the amount of vector determined above was kept constant 
and different amounts of the genomic DNA were used. The ligation mixtures in an 
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vector: insert ratio of 1:3 were transformed into E. coli MM294-4. The amount of 
genomic DNA that gave the most amounts of transformants was chosen. 
 
3.4.3 Construction of the genomic library in E. coli 
 
The library was constructed in a highly transformable E. coli strain MM294-4 using the 
B. subtilis-E. coli shuttle vector constructed in this study (pNDW1). The PstI library gave 
inserts that were ≥1Kb (figure 3.40). The average number of transformants obtained per 
ligation reaction was desirable, 586 transformants were obtained. The statistical 
calculation of the probability (P) that any fragment of the genome would be represented 
in the library was done using the formula of Clarke and Carbon, 1976:  
      
    
       N = In (1-P) ⁄ In [1-(a ⁄ b)]     where N=number of clones  
       P= probability (95%) 
        a= average insert size 
        b= genome size (assumed to be 4.5x 10
6
) 
 
Using the formula above the number of clones required to represent the library was 
determined to be 6 608 clones.  
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Figure3.40: Independent clone digested with PstI from library construction. Lane 1 and 
12 are molecular weight markers. Lanes 2-11 are clones digested with PstI to determine 
the insert sizes. 
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4. DISCUSSION 
    
Plasmids isolated from Staphylococcus aureus also replicate in Bacillus subtilis. That led 
to development of gene cloning technology in B. subtilis aided by the construction of 
vectors that are maintained in both B. subtilis and Escherichia coli. Gene cloning directly 
in B. subtilis as a primary host is relatively inefficient so it is preferable to conduct 
cloning steps with a shuttle plasmid in E. coli then transfer the recombinant plasmids into 
B. subtilis (Bruckner, 1992; Sullivan et al., 1984). Vectors of this type allow the use of 
well-developed techniques for the isolation and manipulation of DNA in E. coli. The 
resulting hybrid molecules can then be introduced into B. subtilis by transformation. 
Gryzan et al. (1980) have also shown that bi-functional plasmids are of great importance 
because the generation of hybrid plasmids by direct transformation of ligation mixtures 
into B. subtilis is very inefficient probably due to the inability of plasmid monomers to 
transform competent B. subtilis (Canosi et al., 1978). Most plasmids functioning in both 
B. subtilis and E. coli are based on the use of the rolling cycle plasmid isolated from S. 
aureus. In this study I have also adopted the same approach, using plasmid pC194.  
 
This was joined to plasmid pEcoR251 which carries an EcoRI endonuclease gene, giving 
a positive selection shuttle vector. The positive selection is due to insertional inactivation 
of the EcoRI endonuclease gene providing a simple method for selecting recombinant 
plasmids. E. coli-B. subtilis shuttle vectors have been previously constructed, and 
selection in these plasmids is by insertional inactivation of a resistant marker (Gryczan et 
al., 1980; Sullivan et al,. 1984)). This selection procedure can be time consuming as 
transformants have to be screened for loss of a resistant marker as an indication that 
foreign DNA has been inserted.  Vieira and Messing (1982) constructed shuttle plasmids 
that contain a fragment of the lacZ gene which is functional in α-complementation. 
Upstream of this is an array of unique restriction sites and insertion of DNA into any of 
these blocks expression, causing a loss of α-complementation and resulting in a Lac
- 
phenotype. Transformants containing inserts are readily detected directly by blue/white 
screening on medium supplemented with the chromogenic substrate X-Gal. With 
pNDW1 one has the advantage of only getting recombinant transformants because those 
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that do not contain an insert will be killed by the endonuclease activity of the suicide 
gene. 
  
Shuttle vectors based on plasmids such as pUB110, pC194 and pE194 replicate stably in 
B. subtilis, but addition of recombinant DNA may confer structural instability and 
sometimes segregational stability. The molecular basis for this is the mode of replication. 
These plasmids replicate by a rolling circle mechanism producing single-stranded DNA 
as an intermediate, and short direct repeats within this single-stranded DNA may lead to 
the deletion of one of the repeats (Bron et al., 1987; Nguyen et al., 2005). Instability is 
also observed when a relatively small foreign DNA fragment results in structural and/or 
segregational stability (Grkovic et al., 2003). However, I found that plasmid pNDW1 and 
others I made did not show any evident structural instability. With pNDW1 the Bacillus 
subtilis and Staphylococcus aureus cells carrying the plasmid or clones of the plasmid 
were selected for chloramphenicol resistance, but this phenotype was only observed when 
the cells were incubated overnight. This suggested that the enzyme chloramphenicol 
acetyltransferase was expressed at low levels such that when allowed to grow overnight 
the level of expression would be enough to cause the aforementioned phenotype.  
 
Plasmid pNDW1 without any insert was able to replicate in S. aureus suggesting that the 
suicide gene was not expressed in this species. That is in contrast to B. subtilis and E. 
coli. When pNDW4 and the same plasmid carrying a PstI B. polymyxa genomic library 
were used to transform S. aureus, transformants were observed at a high efficiency 
indicating that disruption of the suicide gene gives rise to more transformants. This 
means that this plasmid can be used in S. aureus and selection of recombinant 
transformants would be challenging because the suicide gene is not expressed in this host. 
  
A previous limitation of the EcoR-based system was that there were only four useful 
unique restriction sites: HindIII, BglII, PstI, and SfuI. I improved the shuttle vector I 
made by introducing two new restriction sites for cloning and subcloning purposes, XbaI 
and XhoI. The former generates the same single-stranded ends as AvrII, SpeI, and NheI.  
The latter produces the same single-stranded ends as SalI. The XbaI site was introduced 
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into the suicide gene between the BglII and PstI sites and the XhoI was introduced 
between HindIII and BglII site. These are both relatively early in the gene, desirable since 
studies have shown that positive selection by insertion of DNA towards the 3′ end is 
relatively inefficient (E. Dabbs, personal communication). This may be because such a 
fusion protein still possesses endonuclease activity. Bacillus genomic DNA was 
successfully cloned into pNDW5 at the XbaI site with pNDW7 and XhoI transformants 
were not obtained, probably because of the large size of inserts. Streptomyces 
pseudogriseolus genomic DNA digested with XhoI was used and transformants were 
obtained. It should be borne in mind that the B. subtilis and S. aureus recipients used in 
this work have fully functional restriction systems (Seeber et al., 1990; Waldron, 2006). 
B. subtilis has the BsuM restriction modification system. This system recognizes the 
sequence CTCGAG the same as that of XhoI (Jentsch, 1983). The DNA cloned into 
plasmid pNDW7 has the XhoI site flanking the insert and nucleic was coming from E. 
coli which lacks the appropriate modification system means that the DNA is likely to be 
attacked by the BsuM restriction endonuclease. There are other restriction modification 
systems in B. subtilis such as the BsuF (isoschizomer of HpaII), BsuR (isoschizomer of 
HaeIII) and the BsuB (PstI isoschizomer) (Jentsch, 1983). There are sites for all these in 
the plasmid pNDW1 in S. aureus there is the Sau1 type I restriction modification system 
as well as the Sau3AI type II restriction modification system which recognizes the GATC 
sequence (Seeber et al., 1990; Waldron, 2006). Future work could productively address 
elimination of these activities by gene disruption.  
 
Introduction of these sites was confirmed by sequencing and with XbaI the expected base 
change was observed. When sequencing was done for the XhoI site, the HindIII-BglII 
fragment of the suicide gene of pNDW7 had in-frame deletion of a codon, predicted to 
remove a valine. The corresponding sequence from pEcoR251 revealed that the deletion 
was not present. Therefore it has arisen during the mutagenesis procedure. Removal of 
this valine did not affect the protein as the phenotype was observed when the behavior of 
pNDW7 was determined on a lysogen and a non-lysogen. This was consistent with the 
studies done by Wolfers and co-workers (1986) that the Glu111, Glu 144 and Arg 145 are 
essential for the nucleolytic activity of the EcoRI. They made mutants in which the Glu 
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111 is replaced by Gln, Glu 144 replaced by Gln and Arg 145 replaced by Lys which lost 
most of their endonucleolytic activity. This deletion arose concomitantly with the 
mutation introduced to the EcoRI sequence though usually with Taq polymerase it is a 
one nucleotide deletion not a codon.  
 
Predictions of restriction sites on the double mutant EcoRI gene indicated that there were 
additional restriction sites in addition to those introduced (Figure 3.30). However, these 
are for enzymes that are not useful for cloning as they do not have a definite recognition 
sequence. The restriction enzymes AvaI, PspXI, BsoBI do not have unique recognition 
sequences: 5´-CYCGRG-3´, 5´-VCTCGAGB-3´, and 5´-CYCGRG-3´, respectively.  
 
I used my mutant plasmids to increase the versatility of related vectors. The BglII-PstI 
fragment of pNDW5 was used to introduce XbaI into pDA71 (giving pDA71-1) to 
increase the number of restriction sites to use for cloning. The HindIII-BglII fragment of 
pNDW7 was used to introduce the XhoI site into pEcoR251. The XbaI site in pDA71-1 
was shown to function effectively in cloning of genomic DNA. 
 
Preliminary experiments were undertaken to check if pNDW1 can be used in library 
construction and that a Bacillus gene can be cloned using this system. Auxotrophic 
mutants I made using NTG and counter-selection method did not show specific 
auxotrophic requirement. The PstI genomic library was electroporated into QB917 KIT-8 
strain to complement the histidine and threonine auxotrophy but transformants were not 
observed. Protoplast transformation was successful but the efficiency was low. This 
emphasized again the desirability of generating restriction-deficient mutants of B. 
subtilis. 
 
In conclusion, I constructed a shuttle vector with a positive selection (suicide) function 
replicating in E. coli, B. subtilis and S. aureus and showed cloning of DNA can be done 
by insertional inactivation allowing positive selection of recombinant transformants. I 
improved it by introducing two unique restriction sites allowing cloning of DNA digested 
by any of six additional restriction enzymes. These were used to introduce new restriction 
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sites into pEcoR251 and pDA71 Future work might productively focus on constructing 
non-restricting strains of S. aureus and B. subtilis.  
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6. APPENDICES 
 
APPENDIX A: MEDIA  
 
 
Luria Bertani (LB) broth 
Tryptone  3g 
Yeast extract  1.5g 
NaCl   1.5g 
dH2O   300ml 
 
LB- agar 
Tryptone  3g 
Yeast extract  1.5g 
NaCl   1.5g 
Agar   4.5g 
dH2O   300ml 
 
Brain Heart Infusion (BHI) Broth 
BHI    3.7g 
dH2O   100ml 
 
BHI agar  
BHI    3.7g 
Agar   1.5% 
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dH2O   100ml  
 
Spizizen’s medium (Minimal medium for B. subtilis) 
(NH4)2SO4   2g 
K2HPO4   14g 
KH2PO4   6g 
Na2H (C3H5O (COO) 3 1g 
dH2O    1000ml 
Glucose to final concentration 0.5% and auxotrophic requirement added after autoclaving 
Minimal agar prepared by autoclaving 1.5% agar separately, then adding the salts 
prepared separately and glucose. 
 
10X Stock III buffer 
K2HPO4.3H2O 91.7g 
KH2PO4  26.8g 
MgSO4  1.0g 
dH2O   1L 
Store at room temperature with chloroform added 
 
LBS (LB plus 10.3% sucrose) 
Tryptone  1g 
Yeast extract  0.5g 
NaCl   0.5g 
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Sucrose  10.3g 
dH2O   100ml  
 
DM3 regeneration medium 
4% Agar     200ml 
1M Sodium succinate (pH 7.3)  500ml  
5% Casamino acids    100ml 
10% Yeast extract    50ml 
3.5% K2HPO4 and 1.5% KH2PO4   100ml  
20% Glucose      25ml 
1M MgCl2      20ml   
Filter sterilized 2% Bovine Serum Albumin 5ml 
All the components add up to a liter  
 
APPENDIX B: SOLUTIONS 
A6.1 Solutions used for plasmid preparations from E. coli 
Solution I 
Glucose  50mM 
Tris-HCl  25mM 
EDTA   10mM 
pH 8.0 
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Solution II 
NaOH   0.2M 
SDS   1.0% 
 
Solution III 
Potassium acetate 5M, pH 4.8 
Glacial acetic acid 11.5ml 
dH2O   88.5ml 
 
Ribonuclease 
10mg/ml solution in sdH2O, boiled at 95ºC before use 
 
A6.2 Solutions for plasmid preparations from Gram positives 
TE buffer 
0.5M EDTA  0.2ml, pH 8.0 
1M Tris-HCl  1.0ml, pH 8.0 
dH2O   100ml 
 
TE-SDS (10%) 
SDS   10g 
TE buffer  100ml 
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A6.3 Solutions used for transformations 
CaCl2 Transformation buffer 
Tris-HCl  20mM 
CaCl2    100mM 
pH 7.6-8.0 
 
20% Glucose 
Glucose  4g 
dH2O   20ml 
 
Sucrose, HEPES, MgCl2 and Glycerol (SHMG) buffer 
Sucrose    85.56g   
HEPES    0.24g  
MgCl2    0.20g  
Glycerol    10% v/v  
dH2O    1 liter 
pH 7.0 
 
A6.4 Solutions for protoplast transformation of B. subtilis and S. aureus 
 
2× Sucrose, maleate, MgCl2 (SMM) 
Sucrose   17.12g 
Maleic acid   0.232g   
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Magnesium chloride  0.40g 
dH2O    50ml 
pH adjusted to 6.5 with NaOH 
 
4× Pennassay Broth (adapted from El-Helow et al., 1997) 
Glucose   0.08g 
Beef extract   0.12g 
Yeast extract   0.12g 
Peptone   0.40g 
NaCl    0.28g 
K2HPO4   0.29g 
KH2PO4   0.11g 
dH2O    20ml 
 
SMM plus Penassay broth buffer (SMMP) 
Equal volumes of 4× Penassay broth and 2× SMM buffer 
 
Polyethylene glycol (PEG) 40% w/v 
PEG    40g 
2× SMM buffer  50ml 
dH2O    100ml 
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A6.5 Solution for DNA analysis 
Agarose gels 
Agarose  0.8g (0.4%), 1.6g (0.8%) or 2.4g (1.2%) 
5X TBE  20ml 
sdH2O   180ml 
 
5X TBE buffer 
Tris base  54.0g 
Boric acid  27.5g 
0.5M EDTA  20ml, pH 8.0 
dH2O   1000ml 
 
Bromophenol blue tracking dye 
30% glycerol (w/v) in TE and 0.0025% bromophenol blue  
 
Running buffer (0.5x TBE) 
5X TBE   50ml 
dH2O   450ml 
 
0.5M EDTA pH 8.0 
EDTA   18.6g 
dH2O   1L 
Adjust pH to 8.0 with NaOH 
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1M Tris-HCl pH 8.0 
Tris-HCl  15.8g 
dH2O   100ml 
 
TE-saturated Phenol 
Phenol   14g 
TE buffer  10ml 
 
1M NaCl 
NaCl   5.8g 
dH2O   100ml 
 
A6.6 Solutions for mutagenesis 
10X A-N buffer 
K2HPO4   70.0g 
KH2PO4   26.8g 
Na3C6H5O7 (tri-sodium citrate) 5.0g 
MgSO4      1.0g 
dH2O        1L 
Tris-maleic acid buffer 
200mM Tris 
50mM Maleic acid 
Titrate until desired pH obtained 
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Nitrosoguanidine (NTG) 1mg/ml stock solution 
NTG     0.01g 
Tris-maleate buffer (pH4.3)  1ml 
Microwave for 30 Sec until it has dissolved and do not allow to boil 
Use within three days 
 
Table A6.1 Antimicrobial agents 
Agent   Stock concentration  Solvent  Supplier 
  (mg/ml) 
Ampicillin  100   30%sdH2O  Sigma 
      70% ethanol 
Chloramphenicol 20   ethanol  Boehringer 
Kanamycin  10   sdH2O    
Nalidixic Acid 10   30% sdH2O  Sigma-Aldrich 
      70% ethanol 
Rifampicin  10   methanol  Sigma  
Streptomycin  20   ethanol  Boehringer 
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Table A6.2 List of Chemicals  
Name of the Chemical     Supplier 
 
Agarose       Bio-Rad 
Acetic acid       Merck 
BHI        Oxoid 
Boric acid       Saarchem 
Bromophenol blue      Sigma 
Butanol       uniLAB 
Chloroform       Saarchem 
Calcium chloride      Saarchem 
Casamino acids      Difco 
EDTA        Sigma 
Ethidium bromide      Sigma 
Ethanol       Saarchem  
Glucose       Fluka Biochemika 
Glycerol       Merck    
Glycine       Merck 
Hydrochloric acid      Merck 
HEPES       uniLAB 
Isopropanol       uniLAB 
Magnesium chloride      Sigma-Aldrich 
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Maleic acid       BDH analytical reagents 
Potassium acetate      Sigma 
Dipotassium hydrogen Phosphate    Merck 
Potassium dihydrogen phosphate    AnalaR-analytical reagents  
Phenol        Saarchem  
Polyethylene glycol      Fluka 
Sodium hydroxide      Saarchem 
SDS        Boehringer Mannheim 
Tryptone       Oxoid 
Tris        Saarchem 
Technical agar       Oxoid 
Yeast extract       Oxoid 
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APPENDIX C: PLASMIDS AND MOLECULAR WEIGHT MARKER 
 
 
 
 
Figure A6.1: Plasmid map of pC194. 
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Figure A6.2: Plasmid map of pDA71 (adapted from 
http://seq.yeastgenome.org/vectordb/vector.html). 
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Figure A6.3: Plasmid map of pU18/19 
(http://www.fermentas.com/techinfo/nucleicacids/mappuc1819.htm). 
 
 
 
 
 
Multiple Cloning Sites (MSC) of pU18/19 
 
 
 
 
 
 
 
 
 
Figure A6.4: Multiple cloning site of pUC18 and the MCS of pUC19 is the reverse of 
pUC18. 
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Figure A6.5: Plasmid map of pEcoR251. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6.6: 1KB ladder plus, Fermentas 
(http://www.fermentas.com/catalog/electrophoresis/generulers.htm).  
